List of Abbreviations
SAD — scleral acoustic density
BAR — binocular accommodative response
APR — annual progression rate
dB — decibel, unit of measurement in acoustics
D — diopter
RAR — relative accommodation reserve
IOL – intraocular lens
MAR — monocular accommodative response
ICD — International Classification of Diseases
AAA — amplitude of absolute accommodation
OAA — objective accommodation response
OKL — orthokeratology lenses
OOA — amplitude of relative accommodation
PVHRD — peripheral vitreochorioretinal dystrophy
AL — anteroposterior axis of the eye
PINA — habitual excessive accommodation strain
PD – prism diopter
PTA — habitual accommodation tone
TPA — accommodation resting tone
mCNV — myopic choroidal neovascularization
ISO – International Organization for Standardization
Standartization)
FATT – unit of measurement for contact lens oxygen permeability
Terms and Definitions
Congenital myopia is a specific form of myopia that develops during the intrauterine development of the fetus. Myopia of moderate and high degrees detected at the age under 3 years is generally considered congenital.
Orthokeratology lenses (OKL) are rigid gas-permeable contact lenses of the so-called "reverse geometry" design, which reduce or eliminate refractive errors—myopia and astigmatism—through the programmed modification of the shape and optical power of the cornea. They are used in an overnight wear modality.
Habitual excessive accommodation strain (PINA) is a long-standing excessive accommodation tone that causes myopization of manifest refraction without reducing the best-corrected visual acuity.
Pseudomyopia is a condition in which the manifest refraction is myopic, while under cycloplegia it is emmetropic or hyperopic.
Early-acquired myopia is a form of myopia that develops in the preschool period and often tends to progress rapidly.
Late-acquired myopia is myopia that develops at the age over 18 years.
1. Brief information on the disease or condition
1.1 Definition of the disease or condition
Myopia (from Greek *myo* – to squint and *ops* – eye) or nearsightedness is a disproportionate type of eye refraction in which parallel rays of light are focused in front of the retina, and a circle of light scatter is formed on the retina. Myopia is the most frequent cause of deterioration in distance visual acuity. The diagnosis is established if the myopic refraction under conditions of cycloplegia is 0.5 diopters or more. In unfavorable cases, myopia causes the development of retinal complications, strabismus, decreased corrected visual acuity, and in severe cases leads to disability at working age.
School-aged acquired myopia, is the most common form. Decisive importance in the development of "school" myopia is attributed to near-vision work, especially under unfavorable hygienic conditions, burdened heredity, and accommodation weakness. The signal indicating excessive accommodation strain, which is continuously transmitted to the eye growth control center, prompts it to alter the optical system so as to adapt it to near work without accommodation strain. This is achieved mainly through a moderate elongation of the anteroposterior axis (AL) of the eye.
1.2 Etiology and pathogenesis of the disease or condition (group of diseases or conditions)
The concept of the etiology and pathogenesis of myopia in children is reflected in the three-factor theory of myopia origin proposed by Professor E.S. Avetisov (1999). He developed a model of refractogenesis characteristic of myopia. This theory suggests that the main factors in the origin and progression of myopia are weakened accommodation, hereditary (genetic) predisposition, and weakening of the scleral supporting properties. General somatic diseases, metabolic disorders in the connective tissue system, and other factors, which are often assigned a leading role in the origin of myopia, favor the transition of the cause (near work under conditions of weak accommodation capacity) into the consequence—myopic refraction [1].
The rapid spread of myopia in recent decades in various parts of the world cannot be explained solely from the standpoint of heredity; genetic changes occur too slowly to cause a "myopia boom" [2]. Fundamental experimental animal studies have demonstrated the important role of the visual environment and, in particular, the nature of the optical focusing of the image relative to the retina in regulating eye growth and refraction formation [3,4]. Optical defocus of various signs induced biochemical signaling cascades causing changes in the retina, retinal pigment epithelium, choroid, and ultimately in the scleral matrix [4,5,6,7]. Hyperopic defocus in the fovea (when the focal plane is located behind the retina) accelerated eye growth, whereas myopic defocus (when the focal plane is located in front of the retina), conversely, acted as a signal to slow down its growth. Animal studies have provided convincing evidence that not only central but also peripheral defocus can influence refractive development. The retinal periphery, independently of the fovea, could respond to optical signals by altering the pattern of eye growth depending on the sign of defocus, including within a limited area [8,9,10].
Summarizing the data from experimental studies, J. Wallman and J. Winawer emphasize that visually guided eye growth is controlled by a cascade of locally produced chemical substances—neurotransmitters and neuromodulators—secreted by the retina and causing changes in the scleral matrix depending on the sign of defocus, accelerating or slowing down eye growth [5]. Given that the role of accommodation is to ensure clear vision of objects at various distances, near focusing depends entirely on its function. An accommodation response that does not match the accommodative demand is the source of hyperopic defocus, which apparently triggers the entire cascade of signals for eye growth. Thus, the role of accommodation, specifically its weakness, in the development of acquired myopia remains unchanged [1,11,12,13,14,15,16].
1.3 Epidemiology of the Disease or Condition
The development of myopia generally coincides with the period of school education, which ensures its high prevalence among both the pediatric and adult populations. It is projected that by 2050 the number of myopic individuals in the world will reach 5 billion, and about half of the Earth's inhabitants will become myopic, while in Europe this figure will reach 56.2% [17], entailing significant clinical and economic consequences [18]. According to the results of the all-Russian medical examination, the incidence of myopia among children and adolescents increased 1.5-fold between 1990 and 2000. By 2000, the frequency of myopia among school graduates reached 25–30%, among gymnasium and lyceum graduates—50%, with high myopia accounting for 10–12% [19]. By 2017–2018, the prevalence of myopia among 1st-grade students was 2.4%, among 5th-grade students—19.7%, and among school graduates—38.6%, while among gymnasium graduates this indicator reached 50.7% [20]. The highest prevalence rates of myopia are registered in the populations of East and Southeast Asian countries—up to 96% [21,22,23,24]. There is evidence of an increase in its prevalence in European countries [18] and the USA [25,26]. It is assumed that the increase in myopia prevalence is associated with a higher level of education [18,27]. Among adults born in the first three decades of the 20th century, the prevalence of myopia was less than 10%; among those born in the second half of the 20th century, the prevalence of myopia increased to 21–30% [28]. Despite the undoubted successes achieved in recent years in the prevention and treatment of this disease, it frequently leads to irreversible changes in the fundus and a significant decrease in vision at a young, working age.
The conditions for the onset of complicated myopia are laid down during the period of active myopia progression, which coincides with schooling. The detection, prevention of development and progression of myopia and its complications must be carried out precisely during this period [19].
1.4 Features of Coding the Disease or Condition
H52.1 - Myopia.
1.5 Classification of the disease or condition
In clinical practice, the classification proposed by Professor E.S. Avetisov (1999) is most frequently used [1].
Clinical classification of myopia (according to E.S. Avetisov)
By degree:
- Low degree (up to 3.0 D);
- Moderate degree (3.25–6.0 D);
- High degree (6.25 D and more).
By age of onset (clinical forms of myopia):
- Congenital;
- Early-acquired (in preschool age);
- School-aged acquired;
- Late-acquired (in adulthood).
By interocular refraction difference:
- Isometropic;
- Anisometropic.
By presence or absence of astigmatism:
- Without astigmatism;
- With astigmatism.
By course:
- Stationary;
- Slowly progressive (less than 1.0 D per year);
- Rapidly progressive (1.0 D or more per year).
By presence or absence of complications:
- Uncomplicated;
- Complicated.
By stage of functional changes in a complicated course (best-corrected visual acuity):
I. Visual acuity 0.8–0.5;
II. Visual acuity 0.4–0.2;
III. Visual acuity 0.1–0.05;
IV. Visual acuity 0.04 and lower.
The International Myopia Institute (IMI) suggests distinguishing myopia into:
- Axial;
- Refractive [29].
Such a classification was proposed by E.Zh. Tron as early as 1934 [30,31] and remains important for determining the feasibility of surgical interventions in myopia. However, clear criteria for differentiating these two forms based on axial length have not been established.
For the clinical assessment of peripheral dystrophies occurring in the complicated course of myopia, the classification by William L. Jones, 2006 is used [32]. It is very detailed and distinguishes: I. Conditions predisposing to retinal detachment (rhegmatogenous degenerations); II. Conditions not predisposing to retinal detachment (non-rhegmatogenous); III. Retinal tears.
Peripheral retinal degenerations
I. Conditions predisposing to retinal detachment (rhegmatogenous degenerations):
1.1. Lattice degeneration;
1.2. Snail-track degeneration;
1.3. Vitreoretinal tufts:
1.3.1. Non-cystic retinal tufts;
1.3.2. Cystic retinal tufts;
1.3.3. Retinal tufts with zonular traction.
1.4. Meridional folds, isolated bays of the ora serrata, and peripheral retinal excavations;
1.5 "White-without-pressure" and "white-with-pressure" degeneration.
II. Conditions not predisposing to retinal detachment (non-rhegmatogenous):
2.1. Paving-stone (cobblestone) degeneration;
2.2. RPE hyperplasia;
2.3. RPE hypertrophy;
2.4. Peripheral cystoid degeneration;
2.5. Ora serrata pearls;
2.6. Retinal drusen;
2.7. Frost-like degeneration.
III. Retinal tears:
3.1 Flap or horseshoe tear;
3.2 Giant tear;
3.3 Tear with an operculum;
3.4 Avulsion (dialysis);
3.5 Holes (atrophic retinal breaks)
The most convenient for the clinical evaluation of pathological changes in the central fundus in myopia are the International Photographic Classification and Grading System (META-PM) [33] (Table 1) and the ATN classification system, which accounts for the atrophic (A), tractional (T), and neovascular (N) components (Table 2) [34].
Table 1. International Photographic Classification and Grading System for Myopic Maculopathy (META-PM)
Category 0 (C0) | No myopic retinal degenerative lesions |
Category 1 (C1) | Tessellated fundus |
Category 2 (C2) | Diffuse chorioretinal atrophy |
Category 3 (C3) | Patchy chorioretinal atrophy |
Category 4 (C4) | Macular atrophy |
Three additional features supplementing these categories were defined as "plus" lesions: lacquer cracks, mCNV, and Fuchs spot.
Table 2. ATN classification system for myopic maculopathy, accounting for the atrophic (A), tractional (T), and neovascular (N) components [34]
Atrophic component (A) | Tractional component (T) | Neovascular component (N) |
A0: no myopic retinal changes | T0: no macular schisis | N0: no mCNV |
A1: tessellated fundus | T1: inner or outer foveoschisis | N1: macular lacquer cracks |
A2: diffuse chorioretinal atrophy | T2: inner + outer foveoschisis | N2a: active mCNV |
A3: patchy chorioretinal atrophy | T3: foveal detachment | N2s: scar / Fuchs' spot |
A4: complete macular atrophy | T4: full-thickness macular hole | |
T5: macular hole + retinal detachment |
1.6 Clinical presentation of the disease or condition
Patient complaints are limited to decreased distance visual acuity.
Decreased distance visual acuity usually appears at the age of 9–10 years, sometimes earlier. Cases of decreased distance visual acuity in preschool age are referred to as early-onset myopia; it more frequently develops in children who learn to read and write early, use digital devices, and in children with pseudomyopia. Myopia is frequently detected in children of myopic parents [35,36,37,38,39,40]. Children with myopia frequently suffer from acute respiratory infections and have chronic diseases [41,42].
Objective refraction measurement reveals myopic refraction under non-cycloplegic and cycloplegic conditions. Upon visometry, uncorrected distance visual acuity is reduced. When negative lenses fully compensating for myopic refraction are placed before the eye, visual acuity increases to 1.0 or higher. Relative accommodation reserves (RAR) are lower than age-related normal values. Repeated refraction measurements in children reveal a higher degree of myopia in the majority of cases—the disease tends to progress, which is particularly pronounced at the age under 14–16 years. In adults, myopia is most often stable; however, against the background of significant visual load, severe somatic diseases, stress, etc., late-onset myopia may develop or previously stable myopia may progress.
In myopia, binocular functions are preserved in most cases. No alterations of the anterior segment of the eye are detected. Media are typically clear, but in high and especially congenital myopia, vitreous body destruction is observed [43,44].
Peripapillary fundus changes are widespread in children and adults with myopia, among which light arc reflexes, myopic cones (crescent, true cone, and circular cone or false staphyloma) are commonly distinguished. Degenerative myopia is characterized by the formation of a true staphyloma—a protrusion of the posterior segment of the eye representing posterior scleroectasia. The prevalence of true staphylomas increases from 1.4% in eyes with an axial length of 26.5–27.4 mm to 71.4% with an AL of 33.5–36.6 mm [45,46].
In children, central zone changes are generally not observed, with the exception of congenital myopia. In congenital myopia, changes in the paramacular region and myopic maculopathy develop already in childhood [43,44,47,48].
Pathological changes in the macular region (occurring predominantly in adults) during the development of degenerative myopia include a tessellated ("tiger-stripe") fundus, lacquer cracks (linear or stellate ruptures in Bruch's membrane, retinal pigment epithelium, and choriocapillaris), diffuse and patchy chorioretinal atrophy, mCNV, and macular atrophy, as well as various variants of tractional changes [49].
Characteristic dystrophic changes are observed in the peripheral fundus in children and adults [32,50,51,52,53,54,55]. See also the clinical guidelines "Peripheral Retinal Degenerations".
2. Diagnostics, medical indications and contraindications for diagnostic methods
Criteria for establishing the diagnosis of myopia: based on refraction examination under cycloplegia — spherical equivalent refraction values corresponding to myopic refraction of 0.5 D or greater [29].
It is recommended to perform an initial ophthalmologist consultation/examination (B01.029.001) and follow-up ophthalmologist consultation/examination (B01.029.002) for children and adults with myopia or at risk of its development, using diagnostic tests in the following order: identification of risk groups for the development and progression of myopia, detection of myopia, assessment of its degree, evaluation of the severity of functional disorders accompanying myopia, identification of risk factors for myopia progression, assessment of myopia progression by the annual progression rate (APR), and detection of potential retinal complications for the purpose of diagnosis and monitoring of myopia, followed by determining the management and treatment strategy [40,53,56,57,58,59].
GPP CLEL 4Level of Evidence Recommendation C (Level of Evidence – 4)
It is recommended during the initial ophthalmologist consultation/examination (B01.029.001) to classify the following children as being at risk for the onset and progression of nearsightedness: children of myopic parents; children with pseudomyopia; children with myopia first detected in preschool age; children with hyperopia of less than +0.5 D upon school entry; children with reduced accommodation (amplitude and NAR, accommodative response); children with habitual excessive accommodation effort (HEAE) and/or esophoria; children who started reading early; children attending gymnasiums, lyceums, etc.; debilitated children, those with prolonged and frequent illnesses and/or chronic diseases, and those living in unfavorable climatic and ecological zones, for the timely detection of the development and progression of myopia [1,20,39,40,56,57,58,59,60,61].
GRC CLEL 4Grade of Recommendation C (Level of Evidence – 4)
2.1 Complaints and Anamnesis
It is recommended when taking the anamnesis and complaints in ocular pathology (A01.26.001) in children and adults with myopia to assess complaints of decreased distance visual acuity; in the history of the present illness and personal history, special attention should be paid to the age at which the decrease in vision was first detected, family history, living conditions, visual load, previous correction, and physical activity in order to determine further examination, correction, and treatment tactics [40, 57, 59, 62, 63].
Level of Evidence AGrade of Evidence 2Level of Recommendations A (Grade of Evidence – 2)
Comments: complaints – patients with myopia present with complaints of decreased distance visual acuity. In cases of high and congenital myopia, patients complain of decreased distance and near visual acuity.
History of the present illness – time of detection of myopia. When the first glasses were prescribed. When the last glasses were prescribed and which ones. Refraction dynamics (according to previous examinations, previously dispensed glasses, from the patient's words). What treatment was received previously.
Personal history – family history of myopia. Characteristics of the mother's pregnancy and childbirth. Past illnesses. Presence of other diseases and allergies. Characteristics of visual load, physical education, sports, and other activities. Characteristics of the area of residence. Time spent outdoors.
2.2 Physical Examination
It is recommended, as an additional diagnostic method, to measure joint mobility (goniometry) (A02.04.003) to detect joint hypermobility in children with progressive myopia and a high risk of its development in order to assess and monitor the condition of the musculoskeletal system and connective tissue, identify an increased risk of impaired scleral supporting function, and predict the development and progression of myopia [64, 65].
le level BQoE 3Level of Evidence B (level of trustworthiness of evidence – 3)
Comments: joint hypermobility is assessed by five criteria:
1) ability to passively bring the thumb to the flexor surface of the forearm;
2) passive hyperextension of the metacarpophalangeal joints by more than 60 degrees;
3) hyperextension of both elbow joints by more than 10 degrees;
4) hyperextension of both knee joints by more than 10 degrees;
5) ability to touch the floor with palms when bending forward with knees straight.
If three or more signs of joint hypermobility are detected, along with other signs of connective tissue pathology, the patient is diagnosed with an increased risk of impaired scleral supporting function and progressive myopia.
2.3 Laboratory Diagnostics
Not recommended
2.4 Instrumental Diagnostics
It is recommended to perform visometry (A02.26.004) without correction, in existing glasses, and with optimal correction in children and adults with myopia in order to assess visual acuity [1, 66, 67, 68].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
Comments: visometry in children under three years of age is performed approximately – determining whether the child has object vision. More precise measurement is possible using the preferential looking test or optokinetic nystagmus recording [69, 70].
Visometry in children aged three years and older is performed using charts: from 3 years of age, using the children's silhouette picture chart [69, 70].
In children over 5 years of age and in adults, visometry is performed using Landolt rings or "E" tests. These results are the most accurate.
The value of visual acuity is taken as the chart line in which all symbols are correctly identified.
It is recommended to perform refractometry (A03.26.008) in children and adults with myopia under natural conditions by determining refraction using a trial lens set (A02.26.013), uncycloplegic autorefractometry (A12.26.016), and/or skiascopy (A02.26.014) in order to determine dynamic ocular refraction, detect and monitor myopia [1, 67, 68, 71, 72].
GCR CGrade of Recommendation C (Level of Evidence – 5)
Comments: subjective refraction assessment determines the weakest negative lens that achieves maximum visual acuity [1, 68]. In children, subjective refraction is performed as soon as age permits.
It is recommended to perform objective refractometry (A03.26.008) under conditions of cycloplegia in children and adults with progressive myopia using autorefractometry, skiascopy (A02.26.014), and/or subjective refraction testing using a trial lens set (A02.26.013) in order to determine and monitor static ocular refraction and the degree of myopia [1, 67, 68, 71, 72].
GCR CGrade of Recommendation C (Level of Evidence – 5)
It is recommended to instill 1% cyclopentolate eye drops into the conjunctival sac, 1–2 drops twice with an interval of 15–20 minutes, for diagnosis and induction of adequate cycloplegia in children aged 3 years and older with myopia and adults with progressive myopia, as an anticholinergic agent for determining refraction [73, 74, 75].
GCR BLEL 2Grade of Recommendations B (Level of Evidence – 2)
It is recommended to instill 1% tropicamide eye drops into the conjunctival sac, 1–2 drops twice with an interval of 5 minutes, for diagnosis and induction of cycloplegia in children aged 6 years and older with myopia and adults with progressive myopia, as an anticholinergic agent for determining refraction [73, 74, 75].
GCR BLEL 2Grade of Recommendations B (Level of Evidence – 2)
Comments: for diagnostic refraction testing, instillation of 1–2 drops of 1% tropicamide** eye drops into the conjunctival sac twice with an interval of 5 minutes induces less profound cycloplegia than 1% cyclopentolate [73, 74].
It is recommended to use #atropine** 1% in children starting from 7 years of age and in young adults with myopia to induce maximum cycloplegia in special and expert cases [1, 70, 73].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
Comments: to achieve maximum cycloplegia, #atropine** 1% is instilled twice daily for 3 days; on the fourth day, #atropine** is instilled once 1–2 hours before the ophthalmological examination [70]. Instillations of #atropine** 1% are used when the use of 1% cyclopentolate and 1% tropicamide** is impossible due to allergies or other reasons, or when 1% cyclopentolate and 1% tropicamide** fail to induce sufficient cycloplegia for refraction testing. Atropine** eye drops of other concentrations are not registered in the state register of medicines.
It is recommended, as an additional refractometry method (A03.26.008), to study peripheral refraction in children with myopia in order to assess the impact of peripheral refraction on refractogenesis, select the optimal correction method, and evaluate its efficacy over time [76, 77, 78, 79, 80, 81].
Level of Recommendations CLevel of Evidence 3Level of Recommendation C (Level of Evidence – 3)
Comments: peripheral refraction is studied in research settings to predict the course of progressive myopia.
Relative peripheral hyperopia, or hyperopic peripheral defocus, accelerates eye growth and the development of myopia. Relative peripheral myopia, or myopic peripheral defocus, inhibits eye growth and the progression of myopia [76, 77, 78, 79, 80, 81, 82].
To determine peripheral refraction, the refraction corresponding to the periphery of the nasal and temporal retinal zones is measured at a metered gaze deviation of 15º or 30º in the respective direction, and the axial (central) refraction is subtracted from it. The algebraic difference indicates the magnitude and sign of peripheral defocus [81].
For example, Rcenter = -5.0 D, Rperiph = -4.0 D. (-4.0) – (-5.0) = 1.0. Relative peripheral hyperopia of 1.0 D.
It is recommended to perform subjective accommodation testing (A02.26.023) in children over 7 years of age and adults with myopia to determine treatment and correction tactics, select addition, and evaluate their efficacy [83, 84, 85, 86, 87].
le level CLevel of Evidence C (level of trustworthiness
of evidence – 5)
Comments: amplitude of absolute accommodation (AAA)– the difference in refraction of one eye when focused on the nearest (punctum proximum, p.p., PP) and furthest (punctum remotum, p.r., PR) points of clear vision, expressed in diopters. AAA is measured monocularly.
Amplitude of relative accommodation (ARA) – the difference in refraction under conditions of maximum accommodation tension and relaxation during binocular fixation of a stationary object located at a finite distance from the eye, expressed in diopters.
ARA is measured binocularly, with the text placed at a distance of 33 cm under conditions of full distance correction and presence of binocular vision.
The positive and negative parts of relative accommodation are determined: the maximum tolerated power of negative and positive lenses when reading text with both eyes corresponding to a visual acuity of 0.7 (text No. 4 of the D.A. Sivtsev chart). The sum of the absolute values of the positive and negative parts constitutes the ARA.
Special importance is attached to the positive part of relative accommodation – the power of the maximum negative lenses – the positive relative accommodation (PRA) reserve. It is designated as PRA. This is the reserve (unexpended) part of accommodation that can potentially be used. A decrease in PRA indicates a high risk of myopia onset and progression. An increase in PRA is a favorable criterion when assessing the effectiveness of treatment and the prognosis of myopia progression.
The negative (expended) part of relative accommodation, determined using positive lenses, also has diagnostic value.
When reading text at a distance of 33 cm under full correction of ametropia, the negative part of relative accommodation should be 3.0 D. Lower values indicate undercorrection (i.e., inadequate correction) of existing myopia or accommodation spasm, while higher values indicate overcorrection of myopia. In both cases, clarification of objective cycloplegic refraction is required.
Normal age-related values of PRA and NRA are presented in Table 3.
Table 3. Normal age-related values of accommodation parameters
Age, years | PRA, D | NRA, D |
|---|---|---|
7-9 | 3 | 7 |
10-14 | 4 | 9 |
15-19 | 4 | 10 |
20-24 | 3 | 9 |
25-30 | 3 | 8 |
30-39 | 2 | 5 |
40-49 | 0,5 | 2 |
50 and older | 0 | 0 |
PRA values greater than 5.0 D are always overestimated. Obtaining overestimated PRA values indicates a dissociation between accommodation and convergence, the exclusion of one eye from the reading process, and the recording of absolute rather than relative accommodation [83,88].
It is recommended to use objective methods for studying accommodation (A02.26.023) in children and adults with myopia as additional methods for a detailed study of accommodation function and determining the tactics of correction, treatment, and objective assessment of their effectiveness over time [71,83,88,89,90,91,92].
LeRR CLoE 4Level of recommendation confidence C (level of evidence – 4)
Comments: methods are based on the objective recording of changes in dynamic refraction in response to a change in the accommodative stimulus—the objective accommodative response (OAR). In patients with progressive myopia, the OAR is usually reduced. An increase in the OAR is a favorable criterion when assessing the effectiveness of treatment and the prognosis of myopia progression [88,89].
Methods of objective accommodometry, computer accommodography, and dynamic retinoscopy (skiaskopy) are used [88,89,90,91,92].
Objective accommodometry makes it possible to study the OAR, which is measured under conditions of emmetropization at various distances. During binocular fixation, the binocular accommodative response (BAR) is measured, and during monocular fixation, the monocular accommodative response (MAR) is measured [89].
Computer accommodography allows for the graphical recording of changes in eye refraction when presenting a visual stimulus at different distances in the form of a bar chart. In addition to the magnitude of the accommodative response to the presented standard stimulus, the device analyzes accommodative microfluctuations using the Fourier transform method. Computer accommodography allows not only for a quantitative but also a qualitative assessment of the ciliary muscle function and monitoring of its state during treatment [91,92].
It is recommended to study binocular interaction in children and adults with myopia: determining the nature of vision, heterophoria (A02.26.024), studying convergence (A02.26.026), determining the AC/A ratio, studying eye mobility (A02.26.028), and in concomitant strabismus, measuring the angle of deviation (A02.26.010) in order to detect and dynamically assess functional disorders associated with myopia and to determine the tactics of treatment and correction [1,67,93,94,95,96, 97].
GCR CLOE 5Grade of Recommendation C (Level of Evidence – 5).
It is recommended to perform ultrasound examination of the eyeball (A04.26.002), ocular ultrasound biometry (A04.26.004), or optical biometry of the eye (A05.26.007) in children with myopia and the risk of its development, as well as in adults with progressive myopia with axial length (AL) determination and determination of scleral acoustic density (SAD) in children (A12.26.017) for the purpose of diagnosing myopia, monitoring the course (progression rate) of myopia, predicting peripheral dystrophies, and determining indications for scleroplasty [78,96,98,99,100,101,102,103,104,105].
GDR CLE 5Grade of recommendation C (level of evidence – 5)
Comments: AL determination is recommended as the primary diagnostic method and is performed at least once a year. SAD determination is recommended as an additional study method.
AL determination has diagnostic value in the differential diagnosis of myopia and accommodation spasm.
It is recommended to perform biomicroscopy of the eye (A03.26.001) in children and adults with myopia to detect concomitant pathological changes of the anterior segment of the eye, contraindications to contact lens correction and functional treatment [1,67,68, 96].
GDR CLE 5Grade of recommendation C (level of evidence – 5)
It is recommended to perform ophthalmoscopy (A02.26.003) of the central and peripheral fundus under conditions of mydriasis using direct and indirect ophthalmoscopy, including binocular, fundus biomicroscopy (A03.26.018), examination of the peripheral fundus using a Goldmann three-mirror lens (A03.26.003), fundus biomicrophotography using a fundus camera (A03.26.005.001), localization of retinal tears (A03.26.017), and optical examination of the retina using a computer analyzer (A03.26.019) in children and adults with myopia for the early detection of retinal pathological changes, symptoms of degenerative myopia, and determination of management tactics: prescribing conservative treatment and/or the need for laser photocoagulation of dystrophic areas and retinal tears, and surgical treatment [1,32,33,34,52,53,54, 106,107,108,109,110,111,112].
GDR CLE 5Grade of recommendation C (level of evidence – 5)
It is recommended that children and adults with myopia undergo ophthalmoscopy (A02.26.003) of the central and peripheral fundus under conditions of mydriasis at each examination to detect dystrophic changes in the fundus characteristic of myopia [1,32,33,34,52,53,54,106,107,108,109,110,111,112,113].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
Comments: dystrophic changes in the peripheral and central retina serve as the direct cause of the reduction and loss of visual functions in complicated myopia, often leading to the development of retinal detachment [52,53,54,55,98,109]. Dystrophic changes in the central fundus occur: in childhood only in congenital myopia (lacquer cracks, coin-shaped hemorrhages, and neovascular membranes); in adolescence (after 14 years of age) in congenital and early-acquired myopia; in so-called school myopia, myopic maculopathy occurs only in adults, usually after 30 years of age [52,54,55].
Peripheral vitreochorioretinal dystrophies (PVCRD) in all forms of myopia develop already in childhood, and their frequency significantly increases with age, degree and rate of myopia progression, size of the eyeball, and duration of the disease. The "peak accumulation" of PVCRD in children and adolescents is the age of 11-15 years, when their frequency increases 3-4 times. The most frequent localization of lattice degeneration and retinal tears is the upper parts of the temporal half of the fundus, as well as the 11-13 and 5-7 o'clock zones. It is these parts of the fundus that require particularly careful examination during ophthalmoscopy [53,54,109].
It is recommended to use combinations of tropicamide + phenylephrine as a mydriatic agent in diagnostic ophthalmological procedures before ophthalmoscopy (A02.26.003), instilling 1-2 drops 15-30 minutes before the procedure in adults with stable myopia to achieve mydriasis [106,107,108,114].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
It is recommended to use the classification of PVCRD by E.O. Saksonova et al. for patients with myopia with PVCRD to determine treatment tactics [52,55,67,115].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
Comments: the classification by E.O. Saksonova et al. [52] is more convenient for clinical and scientific purposes, is used to describe the fundus in myopia [53,55,67,115], and is more widespread in our country than the more detailed classification by W.L. Jones, 2006 [32]. The classification of PVCRD by E.O. Saksonova et al. is presented in Table 4.
Table 4. Classification of PVCRD by E.O. Saksonova et al.
Types of PVCRD | Clinical Forms |
|---|---|
Equatorial | - lattice; - isolated retinal tears; - pathological equatorial hyperpigmentation. |
Paraoral | - cystic; - peripheral degenerative retinoschisis; - chorioretinal atrophy. |
Mixed forms |
It is recommended to perform ophthalmotonometry in children and adults with myopia (A02.26.015) to detect open-angle glaucoma and other pathological changes concomitant with myopia [116,117,118,119].
GCR BLoE 3Level of Evidence B (Level of Confidence of Evidence – 3)
Comments: to measure intraocular pressure in children and adults, the following are performed: Maklakov applanation tonometry (under local anesthesia); non-contact tonometry (used for screening); indentation tonometry, Goldmann tonometry (under local anesthesia); digital palpation or transpalpebral tonometry (if the above methods cannot be performed [120,121]).
Maklakov intraocular pressure values increase by approximately 0.5 mmHg per year from birth to age 12, rising from 12±2 mmHg at birth to 18±3 mmHg by age 12. Progression of myopia can occur against IOP values corresponding to the upper limit of normal (18–22 mmHg – 31% of cases), mid-normal values (14–17 mmHg – 49% of cases), and the lower limit of normal (8–13 mmHg – 20%).
At high IOP values (24–28 mmHg by Maklakov) in children and adults with progressive myopia, and in adults over 40 years of age with progressive myopia at any IOP values, corneal pachymetry is required (A03.26.011). In 98% of cases, an increase in central corneal thickness to 550 μm or more is detected. In such cases, correction of IOP readings is not required. In 0.5–1% of cases in adolescents with myopia and central corneal thickness of 550 μm or less, increased IOP may indicate juvenile glaucoma [116,117].
Static perimetry (A02.26.005) and automated visual field perimetry (A03.26.020) are recommended in children with myopia over 7 years of age and in adults to detect and monitor pathological changes associated with myopia [1].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
Evaluation of accommodation (A02.26.023) by determining accommodative tone is recommended in children and young adults with myopia, and in children at high risk of developing myopia, to predict the onset and progression of myopia and assess treatment efficacy [56,122].
GoR CLoE 4Grade of recommendation C (level of evidence 4)
Comments: habitual accommodative tone (HAT), or tonic accommodation, is the difference between manifest and cycloplegic refraction.
Tonic accommodation / resting state of accommodation (RSA) is the optical focal state of the eye in the absence of a visual stimulus.
Positive HAT is characteristic of hyperopic eyes and promotes full or partial compensation of hyperopia through accommodative effort to achieve clear vision. Negative HAT (manifest refraction is weaker than cycloplegic refraction) is rarely seen in myopic eyes (5% of cases) [122]. To measure HAT, autorefractometry is performed or subjective refraction values under natural and cycloplegic conditions are compared. High HAT values indicate ciliary spasm / persistent accommodation accommodation excess (PIAN) and are associated with a potentially high rate of myopia progression. Measuring RSA is recommended as an adjunct method. High RSA values are also associated with a higher rate of myopia progression. A decrease in HAT and RSA after treatment is a favorable prognostic sign for the future course of myopia [56].
2.5 Other Procedures
Not recommended
3. Treatment, including drug and non-drug therapies, diet therapy, and pain management
3.1. Optical correction
Optical correction is recommended: prescription of corrective spectacles (A23.26.001), contact lens fitting (A23.26.002), orthokeratology lens fitting (A23.26.002.001) for children and adults with myopia to compensate for refractive and functional visual disorders [1,19,66,68,123].
GDR CLE 5Grade of recommendation C (level of evidence – 5)
Optical correction is recommended for children and adults with myopia in cases of: reduced uncorrected binocular visual acuity; asthenopia, exotropia, or pronounced exophoria; diagnosed congenital myopia, in order to compensate for refractive and functional impairments [1,66,68].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
Comments: when prescribing optical correction, the following should be considered: the degree of myopia, the state of accommodation, convergence, binocular vision, and age.
In children at high risk of developing myopia and children with progressive myopia, it is recommended to prescribe full-time wear of spectacles with corrective spectacle lenses designed to create peripheral myopic defocus to prevent the onset and progression of myopia [11,76,103,124,125,126,127,128,129,130,131,132,133,134,135, 136].
Level of Evidence AGrade of Evidence 2Level of Recommendations A (Grade of Evidence – 2)
Comments: peripheral defocus plays a significant role in refractogenesis [133,134,137]. Peripheral defocus refers to the relative decrease or increase in refractive power moving from the fovea to the peripheral retina. In the former case, this is called relative peripheral hyperopia, or hyperopic defocus; in the latter – peripheral myopic defocus. Hyperopic defocus at the retinal periphery stimulates axial eye elongation and development of axial myopia, whereas myopic defocus, on the contrary, inhibits refractogenesis [78,82,138,139,140].
Special corrective spectacle lenses of various designs can induce low myopic defocus onto the corresponding areas of the mid-peripheral retina [11,103,128,129,131,132,141].
Spectacle lenses designed to create peripheral myopic defocus include progressive/multifocal lenses designed for central vision correction with perifocal increase in peripheral refractive power [130,131,132,133,], single-vision spectacle lenses with integrated rings of highly aspheric lenslets (H.A.L.T.) generating a slowdown signal volume in front of the retina [125,126,128,129,134,142], and single-vision spectacle lenses incorporating multiple defocus segments (D.I.M.S.) [103,127].
Spectacles with progressive/multifocal corrective spectacle lenses designed for central vision correction and peripheral perifocal power increase allow differential correction of central and peripheral ocular refraction along the horizontal meridian and induce myopic (or reduce hyperopic) peripheral defocus in myopic eyes [131,132,133]; when used, they increase accommodative facility and induce positive spherical aberration in the eye. By creating relative peripheral myopic defocus at 15° and even 30° from the fovea, spectacles help slow myopia progression. After 4–5 years of continuous wear of such spectacles, refraction remained stable compared to baseline in 37.5% of cases, and regression was observed in 3.6%. In the remaining cases, refraction increased: mildly by 0.63–1.0 D in 28.6% of cases, by 1.12–2.0 D in 21.4% of cases, and by more than 2.0 D in 8.9% of cases; the annual progression rate (APR) was 0.26 D/year, and axial length (AL) increased on average by 0.46±0.05 mm compared to baseline values. In the control group of children wearing spectacles with single-vision corrective lenses, the mean APR was 0.44 D/year, and AL increased by 0.71±0.09 mm [130]. Corrective spectacles with progressive/multifocal lenses with zero or plus central power can be used for pseudomyopia and other predictors of myopia development in children [39,40,132,133].
Wearing spectacles with single-vision lenses incorporating rings of highly aspherical lenslets reduced myopia progression by up to 67% over two years of follow-up in Chinese children. The increase in refraction was 0.48±0.1 D, and the increase in axial length was 0.28±0.04 mm, provided the spectacles were worn for more than 12 hours a day. In the control group, the increase in refraction was 1.44±0.1 D, and the increase in axial length was 0.69±0.04 mm [126]. In Russian children, myopia progression decreased by 79% over two years of follow-up. The increase in refraction was 0.2±0.06 D, and the increase in axial length was 0.15±0.03 mm. In the control group wearing single-vision lenses without rings of highly aspherical lenslets, the increase in refraction was 0.95±0.08 D, and the increase in axial length was 0.48±0.04 mm [135].
Wearing spectacles with single-vision lenses incorporating multiple defocus segments slowed myopia progression over two years. The increase in refraction was 0.34±0.52 D, and the increase in axial length was 0.20±0.21 mm. In the group wearing single-vision lenses without defocus segments, the increase in refraction was 0.87±0.59 D, and the increase in axial length was 0.49±0.24 mm [127].
It is recommended that when prescribing spectacle correction (A23.26.001) for children with progressive myopia, full correction corresponding to cycloplegic refraction be prescribed to compensate for central refraction, achieve high visual acuity, and normalize accommodation [11,103,126,127,130,143,144,145].
GRC BLEL 2Grade of Recommendation B (Level of Evidence – 2)
Comments: in cases of sharply reduced accommodation and poor spectacle tolerance, undercorrection by no more than 0.5 diopters weaker than the cycloplegic refraction is possible
It is recommended to prescribe alternating anisocorrection (alternating monolateral mild-myopic defocus) to children with progressive myopia up to 2.5 diopters to create an alternating and varying degree of myopic defocus in both eyes in order to prevent the progression of myopia [100,146,147].
GCR BLOE 3Grade of Recommendation B (Level of Evidence 3)
Comments: one eye is corrected to achieve (in spectacles!) a residual myopia of -0.5 diopters, the other eye is corrected to achieve a residual or induced myopia of -1.5 diopters. Binocular vision and high corrected binocular visual acuity are preserved. Two pairs of spectacles (with alternating defocus) are prescribed to be worn every other day. Spectacles are recommended for children aged 7–11 years with low myopia and eso- or orthophoria [100,146,147].
It is not recommended to prescribe single-vision corrective spectacles and contact lenses that do not affect peripheral refraction to children with progressive myopia, with the aim of preventing the hyperopic peripheral defocus induced by these types of correction, which contributes to the progression of myopia [11,17, 81,141,145,148,149,150].
GCR BLeE 2Grade of Recommendations B (Level of Evidence – 2)
Comments: single-vision corrective spectacles and contact lenses that do not affect peripheral refraction maintain or even increase hyperopic defocus across virtually the entire field of view in any gaze direction [11,81,141,148,149,150], and also induce negative spherical aberration in myopic eyes [149,151,152].
It is recommended to prescribe optical correction with addition in cases of reduced accommodative function and/or esophoria in children with myopia, in order to compensate for the accommodation deficit and/or esophoria [11,19,153,154,155,156,157,158].
LoR AGoE 1Level of Recommendation A (Grade of Evidence – 1
Comments: permanent correction with an addition of 0.75–3.0 diopters is prescribed: [66,68,86,87].
It is not recommended to prescribe bifocal and progressive spectacle lenses to children with myopia who have exophoria for near exceeding physiological values, with the aim of preventing disorders of binocular interaction and the development of exophoria decompensation [11,158].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
It is recommended to prescribe transfocal spectacle lenses for vision correction—the design of which allows them to be used for central vision correction and peripheral refractive reinforcement, and features an addition of 1.25 diopters—for the correction of progressive myopia in children with sharply reduced (less than 1.0 diopter) ranges of accommodation in the presence of exo-, ortho-, or esophoria, with the aim of inducing myopic peripheral defocus, supporting accommodation, and preserving binocular interaction [11].
Level of Evidence CGrade of Recommendation 5Level of Clinical Effectiveness C (level of evidence – 5)
It is recommended to provide early, at 1 year of age, continuous-wear correction for children with congenital myopia in order to prevent the development of relative amblyopia [67].
Level of Evidence CGrade of Recommendation 5Level of Clinical Effectiveness C (level of evidence – 5)
Comments: the spherical component correction is prescribed 2.0 diopters weaker than the objectively determined refraction, near-full astigmatism correction and maximally full correction of the refractive difference between the two eyes (up to 6.0 diopters) are prescribed, and contact lens correction should be used whenever possible.
It is recommended to prescribe full spectacle correction (A23.26.001) for distance or continuous wear, taking into account comfort and tolerance, in adult patients with myopia, in order to ensure high corrected visual acuity, adaptation to spectacles, and high visual performance [66,68].
GDR CLE 5Grade of recommendation C (level of evidence – 5)
It is recommended to prescribe an addition (A23.26.001) for near work in adult patients with myopia of presbyopic age, in order to ensure sufficient visual acuity and near-visual performance [66,68,86,87,159,160].
GCR BLoE 3Level of Evidence B (Level of Confidence of Evidence – 3)
It is recommended to determine contact lens fitting parameters (A03.26.010) and fit contact lenses (A23.26.002) for children, adolescents, and adults with myopia if continuous correction of myopia is indicated, in order to compensate for refractive errors and achieve high visual functions [66,68].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
Comments: the advantages of contact lenses over spectacles include a clearer retinal image, reduction of aberrations, absence of prismatic effect, and no restriction of the visual field by the spectacle frame.
It is recommended to determine contact lens fitting parameters (A03.26.010) and fit contact lenses (A23.26.002) that form a myopic defocus—specifically bifocal or multifocal contact lenses—in children with progressive myopia, in order to correct central and peripheral refraction, compensate for accommodative disorders, and prevent progression [11,79,153,161,162,163,164,165,166,167,168,169,170,171,172,173].
LoR AGoE 2Level of Recommendation A (Level of Evidence – 2)
It is recommended to determine contact lens fitting parameters (A03.26.010) and fit monofocal contact lenses (A23.26.002) in children with congenital myopia with and without amblyopia, moderate and high myopia, and anisometropia for effective compensation of refractive and functional disorders [174,175].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
Comments: to prevent the progression of myopia in children with congenital myopia, moderate and high myopia, and anisometropia, it is advisable to additionally prescribe spectacles that create peripheral myopic defocus alongside contact lenses. This combination of two correction modalities is called bioptics [11].
It is recommended to determine contact lens fitting parameters (A03.26.010), perform videokeratotopography (A12.26.019), and fit orthokeratology lenses (OKL) (A23.26.002.001) in children with progressive myopia starting from six years of age, with the aim of correcting myopia and preventing its progression [11,176,177,178,179,180,181,182,183,184,185].
GCR ALEL 1Grade of Recommendations A (Level of Evidence – 1)
Comments: orthokeratology – a method for the temporary reduction or elimination of refractive anomalies: myopia and astigmatism, achieved through programmed modification of corneal shape and optical power using rigid gas-permeable contact lenses for overnight orthokeratology wear. Modern orthokeratology utilizes complex design lenses known as "reverse geometry" lenses, whose back surface consists of 4 or more zones with varying width and curvature ratios. These lenses are made from high oxygen-permeable materials (typically not lower than 100 units according to ISO/FATT). The refractive effect is associated with a decrease in epithelial thickness at the center and an increase in thickness in the mid-peripheral zone due to changes in the shape and size of superficial epithelial cells [185,186,187]. This leads to a flattening of the corneal center and an increase in its curvature in the mid-peripheral zone [177,178]. Uncorrected visual acuity improves as early as after the first night of lens wear and reaches its maximum within a period ranging from one week to one month [177,178].
Orthokeratology significantly slows down the progression of myopia or stabilizes it [153,176,180,181,182,183,184,185]. The technique is recognized as safe. Experimental and clinical studies have proven that effective inhibition of myopia progression and its stabilization are achieved by altering the eye's peripheral refraction with the formation of a peripheral myopic defocus [164,177].
The use of OKL helps increase the range of accommodation and accommodative amplitude to normal age-appropriate values, and these indicators remain stably high throughout the entire period of OKL use, while habitual excessive accommodation (TEA) does not develop. An improvement in dark adaptation time to normal values, an increase in reading speed by 19.9%, an improvement in visual productivity by 20.8%, an increase in the information throughput of the visual analyzer by 33%, and a 2.8-fold increase in the depth of the focal region for distance and 2-fold for near are also noted. This leads to a reduction in visual fatigue and an improvement in visual quality [178], which also contributes to the stabilization of the myopic process.
Indications for OKL prescription:
- Myopia up to -8.0 diopters
- Corneal astigmatism up to 5.0 diopters;
- Progressive myopia; with annual progression rate of more than 1.0 diopter per year combined with scleroplasty;
- Sports and other activities incompatible with spectacles and contact lens correction [177,178,179].
Absolute contraindications to orthokeratology lens (OKL) fitting:
- Inflammatory diseases of the eye, ocular adnexa, and orbit (acute conjunctivitis, acute and recurrent keratitis, scleritis, uveitis, acute and chronic dacryocystitis, blepharitis, meibomianitis, etc.).
- Severe dry eye disease
- Keratoconus, keratoglobus, and other corneal dystrophies
- Malignant neoplasms of the eye and its adnexa
- Decreased corneal sensitivity
- Lacrimal passage obstruction of any etiology
- Chalazion
- Lagophthalmus
- Pterygium, pinguecula
- Nystagmus
- Only seeing eye
- General acute infectious and inflammatory diseases
- Collagenoses, severe immunodeficiency states
- Isotretinoin intake (throughout the entire course of treatment)
- Inability to follow the physician's recommendations [179] and psychological characteristics that prevent safe use of OKL.
Relative contraindications to OKL fitting:
- Irregular astigmatism
- Corneal opacities and scar changes
- Oncological diseases, radiation therapy, and chemotherapy (until treatment is completed)
- Mild and moderate dry eye disease
- Tear film composition abnormalities
- Seasonal allergies
- Endocrine and autoimmune diseases
- Use of glucocorticosteroids.
Complications of orthokeratology correction:
- Complications typical of traditional contact lens wear
The procedure must be performed in specialized facilities and requires a high level of professional skill from an ophthalmologist, knowledge of the principles of the method, and skills in OKL fitting. Modern ophthalmic equipment, including a corneal topographer, is required for the procedure.
Prerequisites for the effective and safe application of the method are regular medical follow-up of patients and strict compliance by patients with lens use and care rules.
This type of correction is temporary, provides high visual acuity, and eliminates the need to wear glasses and contact lenses during the day [177,179,180,181,182,183,184,185].
OKL fitting in adults is possible.
3.2. Functional treatment
It is recommended to prescribe functional treatment, including exercises for training the ciliary muscle of the eye (A19.26.002), laser stimulation of the ciliary muscle (A22.26.021), exercises to restore and strengthen binocular vision (A19.26.001) using optico-reflex training, and hardware treatment for children and adults in cases of progressive myopia, congenital myopia, low values of relative accommodation reserve (RAR) and accommodative amplitude, and accommodative spasm in order to optimize refractogenesis and prevent the progression of myopia [1,188,189,190,191,192].
Level of Evidence AGrade of Evidence 2Level of Recommendations A (Grade of Evidence – 2)
Comments: systematic impact on the accommodation apparatus for the purpose of preventing the onset and progression of myopia helps normalize accommodation tone, increase ciliary muscle performance, enhance the metabolic activity of ciliary body cells, and improve ocular hemodynamics [1,188,189,190].
It is not recommended to perform functional treatment of myopia in children with inflammatory diseases of the eye and its adnexa, in cases of very young age, poor tolerance to procedures, or seizure readiness [193,194].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
It is recommended to perform exercises for training the ciliary muscle of the eye (A19.26.002) 4 times a year in children with progressive myopia to improve accommodation and optimize refractogenesis [191].
GGR ALEL 2Grade of Recommendation A (Level of Evidence – 2)
Comments: 1) The "Mark on the Glass" exercise is performed wearing glasses, daily, once a day, for 1 month. For the first three days, the duration of each exercise – is 3 minutes; for the next three days – 5 minutes; on the remaining days – 7 minutes.
2) The exercise with a "Racket" or a home accommodotrainer is performed for 7–10 minutes for each eye with a 10-minute interval against the background of exercises for 4 weeks; patients are recommended instillation of #phenylephrine 2.5% solution, 1 drop at bedtime, to prevent the progression of true myopia in patients with high visual stress [1,192].
It is recommended to use special training glasses (A23.26.001) at home for children with progressive myopia or a high risk of developing myopia in order to improve accommodative function, binocular interaction, and optimize refractogenesis to prevent the progression of true myopia [195,196].
LeRR CLoE 4Level of recommendation confidence C (level of evidence – 4)
Comments:1). Special training glasses are used, containing optical elements in the form of aspherical lenses with zero (or other necessary) refraction in the geometric center, gradual enhancement of refraction on one side from the center and attenuation on the other. Such glasses can be made with a difference between the refraction in the center of the lens and at its periphery of ±0.25 D, ±0.5 D, ±0.75 D. The sum of the progression and regression values constitutes the magnitude of the dynamic change in the lens refraction. Thus, for a lens with a progression in one direction by 0.5 D and a regression in the other direction by 0.5 D from the geometric center, the change in lens refraction will be 1.0 D – the optimal value for training. When reading, conjugate eye movements force looking along the horizontal meridian of the aspherical lens, in which the refraction alternately and smoothly increases and decreases, causing alternating relaxation and tension of accommodation, exerting a training effect. When wearing such training glasses for two hours a day for 2 weeks, there is a decrease in refraction by an average of 0.21 D in myopia and 0.81 D in pseudomyopia, an increase in accommodative amplitude by 1.5 and 2.0 D, and RAR by 0.8 D and 1.1 D, respectively. Such a training effect helps reduce the risk of developing and progressing myopia. The glasses can be used for two or more hours a day during any visual load, throughout the entire period of risk of developing and progressing myopia [196].
2). Special spheroprismatic training glasses are used, providing a training effect based on the principles of divergent desaccommodation and micro-fogging. The exercises increase RAR by 0.4–0.6 D. The exercises are performed for 5–10 minutes in courses 2 times a year throughout the entire period of risk of myopia development [195].
It is recommended to prescribe exercises to restore and strengthen binocular vision (A19.26.001) and exercises to train the ciliary muscle of the eye (A19.26.002) as optico-reflex training for children and adults with progressive myopia in order to optimize refractogenesis and prevent the progression of myopia [19,188,189,191].
GGR CLEL 4 Grade of Recommendation C (Level of Evidence – 4)
Comments:
1). Accommodation training according to E.S. Avetisov and K.A. Mats is performed binocularly under full correction conditions, in the first 3 days – once a day, on the remaining days – twice a day. At very low starting values of the negative relative accommodation (NRA) / positive relative accommodation (PRA) volume, exercises are performed in a sparing mode: larger text is used for reading, the duration of exercises is shortened, and negative lenses from the trial lens set are changed with a step of 0.25 D. To refine submaximal loads, relative accommodation is determined every 3 days. The optimal criterion for the effectiveness of such training is an increase in RAR. The course consists of 15–20 training sessions. To consolidate the effect, it is recommended to perform the home exercises and training glasses sessions described above.
2). The optical micro-fogging method according to A.I. Dashevsky is performed for each eye separately. The duration of one training session is no more than 15 minutes for each eye. The course of treatment – 10 training sessions.
3). A.I. Dashevsky's divergent deaccommodation method. Prerequisite – stable binocular vision, contraindication – distance exophoria greater than 6.0 prism diopters.
4). The "rocking" method according to V.V. Volkov and L.N. Kolesnikova is used if it is not possible to achieve an increase in uncorrected visual acuity using the methods described above. Treatment is performed monocularly under conditions of full distance correction.
5). The method of combined application of a relaxing effect on the ciliary muscle using "glass atropine" or micro-fogging and divergent desaccommodation training is carried out using positive spherical and cylindrical lenses and prisms. Training can be performed automatically on special devices.
Accommodation training devices can be used from 3–4 years of age [191,192].
It is recommended to prescribe exercises for the restoration and strengthening of binocular vision (A19.26.001) and exercises for training the ciliary muscle of the eye (A19.26.002) as optico-reflex training 2 times a year and alternate them with home exercises for training the ciliary muscle of the eye (A19.26.002) and the prescription of medications for eye diseases (A25.26.001) in progressive myopia in children in order to optimize refractogenesis and prevent myopia progression [19,191,192].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
It is recommended to perform hardware treatment 2–4 times a year and alternate (combine) it with home exercises for training the ciliary muscle of the eye (A19.26.002) and the prescription of medications for eye diseases (A25.26.001) in children with progressive myopia in order to optimize refractogenesis and prevent myopia progression [19,191,192].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
Comments: hardware treatment includes low-intensity laser stimulation of the ciliary muscle – transscleral non-contact exposure of the ciliary muscle using infrared laser radiation. 10 procedures are performed once or twice a day (in the latter case with a 30–40 minute break) 2–4 times a year.
It is not recommended to use the method of video-computer bioelectric correction of the activity of the cortical visual analyzer in children with acquired progressive myopia [19,191,192].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
Comments: it is advisable to use this method for its intended purpose – for the treatment of amblyopia. In progressive myopia, an increase in accommodation tone and even the development of a partial spasm of accommodation is possible after a course of training.
It is not recommended to use pleoptic treatment methods, including those implemented using computer programs, in children with acquired progressive myopia [19,191].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
Comments: such training enhances dynamic eye refraction, increases the positive and negative relative accommodation, inducing a more rapid progression of myopia.
It is recommended to use stimulation of the normal function of the retinal fovea (pleoptic treatment) (A16.26.110) in children with congenital myopia accompanied by amblyopia in order to improve visual functions [67].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
It is recommended to perform magnetophoresis (A17.30.040), electrophoresis of medicinal products for eye diseases (A17.26.001), and other types of physiotherapy, reflexology for eye diseases (A21.26.003), and collar zone massage (A21.01.003.001) in children and adults with progressive myopia to optimize refractogenesis and prevent myopia progression [19,193,194,197].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
Comments: 1) Low-frequency magnetotherapy for the organ of vision and magnetophoresis of medicinal substances. The treatment course consists of 10 ten-minute procedures. 2) Electrophoresis of medicinal products for eye diseases is carried out according to three methods: on closed eyelids (Bourguignon method), through an electrophoretic bath on the open eye, and endonasally. 3) Electroacupuncture and electroacupuncture in reflexology are performed with direct current, the current strength is adjusted until a slight tingling or burning sensation appears at the site of exposure. The duration of exposure to each point is 1–2 minutes. When exposed to general points, a negative polarity current is used; for points in the eye area, a positive polarity current is used. The course of electroacupuncture includes 5–6 procedures, carried out 2–3 times a year. In rare cases, a transient increase in dynamic refraction is possible. 4) Reflexology for eye diseases. To treat myopia, general-action, local, paraorbital, collar zone, and auricular acupuncture points are used. The course of treatment consists of 10 procedures of 20 minutes each, performed daily or every other day. 5) Collar zone massage. It is recommended to perform 10 procedures 2 times a year.
It is recommended to prescribe a therapeutic and health-improving regimen for eye diseases (A25.26.003): physical activity, predominantly outdoor activity (swimming, badminton, tennis, health-improving gymnastics, dancing, slow medium-distance running, etc.) in children with myopia and children with a high risk of developing myopia in order to optimize refractogenesis [62,63,153,198,199].
GCR ALEL 1Grade of Recommendations A (Level of Evidence – 1)
It is not recommended in myopia accompanied by peripheral vitreoretinal degeneration forms predisposing to retinal detachment to engage in physical exercises associated with jumping and weightlifting, straining and breath-holding, timed running, somersaults, pull-ups, and contact sports in order to prevent the development of complications that reduce visual functions [1,19,32,200].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
Comments: for peripheral retinal dystrophies not predisposing to retinal detachment (peripheral cystoid degeneration, cobblestone degeneration, ora serrata pearls, pars plana cysts, white-without-pressure, white-with-pressure), physical education classes are permissible. The degree of myopia is not a decisive indicator when determining clearance for physical education classes [19,200].
3.3. Drug therapy
It is recommended as medical therapy to use instillations of medicinal substances into the conjunctival sac (A14.26.002) affecting accommodation (phenylephrine (S01FB01), tropicamide in combination with other drugs (S01FA56)) in children and adults with progressive myopia accompanied by accommodation disorders and asthenopia, in order to normalize accommodation function and optimize refractogenesis [201,202,203,204,205,206].
GRC CLEL 4Grade of Recommendation C (Level of Evidence – 4)
Comments: medical treatment with phenylephrine and tropicamide in combination with other drugs is used in the complex treatment of myopia along with optical correction and functional treatment. Medical treatment is usually carried out in courses 4 times a year at home, see Table 5
It is recommended to prescribe medicinal products for eye diseases (A25.26.001) - other drugs used in ophthalmology (S01XA) and multivitamins in combination with other agents (A11AB) to children and adults with progressive and/or complicated myopia along with optical correction and functional treatment to prevent the development of chorioretinal dystrophies [19,207,208,209].
GCR CLEL 5Grade of Recommendation C (Level of Evidence - 5)
Comments: drugs with angioprotective and microcirculation-improving action for use in ophthalmology (antioxidant agents) and drugs that improve the functional state of the retina for systemic use in ophthalmology and multivitamins in combination with other minerals are prescribed in courses 2 times a year for home use. Medications used in the complex treatment of progressive myopia are presented in Table 5.
Table 5. Medications used in the complex treatment of progressive and complicated myopia
ATC code | INN | Method of administration and doses | Indications for use in accordance with the instructions |
Phenylephrine 2.5% — eye drops | For children from 6 years and adults, 1 drop 1 time a day at bedtime, 4 weeks, in courses 4 times a year | Prevention of asthenopia and accommodation disorders in patients with high visual load. Treatment of false myopia (accommodation disorders) and prevention of true myopia progression in patients with high visual load | |
Tropicamide in combination with other drugs (S01FA56) | Tropicamide + phenylephrine — eye drops | For children from 12 years and adults, 1 drop 1 time a day at bedtime, 2–4 weeks | For accommodation disorders and therapy of progressive myopia (as part of combination therapy) |
Other drugs for the treatment of eye diseases (S01XA) | Methylethylpyridinol 1% — eye drops | For adults, 1–2 drops 2–3 times a day, 30 days, in courses 2–3 times a year [209] | Treatment of myopia complications |
Multivitamins in combination with other agents (A11AB) | #Multivitamins + other drugs | According to the instructions | In the complex therapy of myopia |
3.4. Surgical treatment
It is recommended focal laser fundus photocoagulation (A22.26.009), sectoral retinal laser photocoagulation (A22.26.029) as barrier laser surgery in children and adults with myopia upon detection of retinal defects: lattice degeneration with thinning; any retinal tears – isolated or associated with lattice or other rhegmatogenous form of degeneration in order to prevent the development of retinal detachment [32,54,115,210,211,212,213,214,215,216]
GDR CLE 5Grade of recommendation C (level of evidence – 5)
Comments: the main goal of treatment – the formation of adhesion of the retina with the pigment epithelium in the defect area. As a result of laser exposure during retinal photocoagulation, delicate pigmented chorioretinal scars are formed.
It is recommended to perform laser surgery under local epibulbar anesthesia (B01.003.004.001) in compliant children and adults with myopia for pain relief [217, 218].
GDR CLE 5Grade of recommendation C (level of evidence – 5)
It is recommended to perform scleroplasty (A16.26.075) or scleroplasty using grafts (A16.26.075.001) in patients with progressive myopia over 8 years of age as the most effective method for treating progressive myopia to optimize refractogenesis and prevent complications [104,219,220,221,222,223,224,225,226,227,228,229,230,231,232,233,234,235].
GRC CLEL 4Grade of Recommendation C (Level of Evidence – 4)
Comments: Scleroplasty is a pathogenetically substantiated method. During scleroplasty, graft materials are placed on the scleral surface (under Tenon's capsule), which are gradually replaced or invaded by newly formed connective tissue. As a result, a single sclera-graft complex is formed, which increases the biomechanical stability of the eye tunics and provides a stabilizing effect.
Various modifications of scleroplasty using donor or synthetic materials are used. Within one to two years after surgery, refraction stabilization is observed in 87%-96% of operated eyes and within one year in 80% of fellow eyes [220].
It is recommended to perform "minor" scleroplasty (A16.26.075)—minimally invasive scleroplasty—in children over 8 years of age with myopia from 3.5 D, if the annual myopia progression rate is 0.75–1.0 D, and the anteroposterior axis (APA) length is no higher than 27 mm, to optimize refractogenesis and prevent myopia progression [219, 224].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
Comments: minimally invasive scleroplasty is characterized by a simple surgical technique and a minimal volume of intervention.
It is recommended to perform "minor" scleroplasty (A16.26.075) under local epibulbar anesthesia (B01.003.004.001) in children with myopia for pain relief [217, 218, 226, 227].
GDR CLE 5Grade of recommendation C (level of evidence – 5)
It is recommended to perform "minor" (minimally invasive) scleroplasty (A16.26.075) first on one eye, and in six months (if an effect is present) on the other eye in children with progressive myopia to optimize refractogenesis and prevent myopia progression [219, 224, 226, 228, 229].
GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)
It is recommended to perform bandaging scleroplasty (A16.26.075.001) in patients with high myopia in cases where the annual progression rate increases again to 1.0 D or more at any stage of treatment (rapidly progressive myopia) to prevent myopia progression and optimize refractogenesis [220, 224].
GCR BLoE 3Level of Evidence B (Level of Confidence of Evidence – 3)
It is recommended to perform "major" (bandaging) scleroplasty (A16.26.075.001) according to the modified Snyder-Thompson technique in patients older than 10 years with myopia exceeding -6.0 D, APA length greater than 26.0 mm, and an annual progression rate greater than 1.0 D to prevent myopia progression and optimize refractogenesis [150, 220, 227, 230].
GCR BLoE 3Level of Evidence B (Level of Confidence of Evidence – 3)
Comments: the modified Snyder-Thompson technique is low-traumatic, effectively stabilizes the myopic process, improves the trophism of the eye tunics, enhances visual functions, and prevents the development of disabling fundus complications. The operation uses a graft made of ophthalmic knitted polyester mesh or donor material formed as a strip 70 mm long and 10 mm wide. Scleral reinforcement can be performed using one of the modifications of the M.V. Zaikova technique, N.N. Pivovarov, or E.S. Avetisov – E.P. Tarutta.
It is recommended to perform repeated scleroplasty (A16.26.075) in patients with an increased risk of myopia progression and an unfavorable prognosis for the efficacy of a single scleroplasty to optimize refractogenesis and prevent the development of chorioretinal dystrophic changes [220, 221, 223, 230, 231].
GCR BLoE 3Level of Evidence B (Level of Confidence of Evidence – 3)
Comments: the tactic and system of scleroplasty for progressive myopia in the most severe category of patients involves staged repeated scleral reinforcement in both eyes (Table 6).
Table 6. Staged schedule of scleroplasty.
Stage I | "Minor" scleroplasty on the eye with stronger refraction; 6–12 months later – "minor" scleroplasty on the fellow eye |
Stage II, 1 year after Stage I in the presence of myopia progression | "Major" scleroplasty on the eye with stronger refraction; 12–18 months later – "major" scleroplasty on the fellow eye |
Performing repeated scleroplasty in high-risk patients reduces the rate of myopia progression by an average of 4 times and ensures its long-term stabilization (up to 10 years) in 75% of cases, while reducing the incidence of chorioretinal dystrophic changes by 2.5 times [220].
It is recommended to perform scleroplasty (A16.26.075.001) with reinforcement of the posterior segment of the eye (A16.26.078) – with local depression of the posterior scleral pole to support the posterior pole in high complicated and congenital myopia in children and adults to reduce tension in the membranes of the myopic eye and alleviate vitreomacular traction [220, 221, 223, 227].
GCR BLEL 3Grade of Recommendation B (Level of Evidence – 3)
Comments: to prevent the further development of staphyloma and damage to the Bruch's membrane–choriocapillaris–pigment epithelium complex, a low-traumatic technology of scleral reconstructive treatment for high complicated myopia is used, involving the creation of a local depression of the posterior pole sclera using an implant made of biologically active polyester mesh with a polymer coating.
The operation uses a graft formed as a strip 70 mm long and 10 mm wide (according to Snyder-Thompson). For local depression of the eye membranes in the posterior pole area, an implant measuring 10x15–20 mm is used, cut out from ophthalmic knitted polyester mesh or donor material and fixed to the middle part of the graft.
In the long-term postoperative follow-up period, persistent flattening of the staphyloma, restoration of the eye shape, improved trophism of its membranes, reduction of myopia degree and refraction stabilization, shortening and stabilization of APA length, increased scleral acoustic density, improved visual acuity, and stabilization of the fundus status and visual functions are maintained.
It is recommended to perform "major" scleroplasty in patients with myopia in a 24-hour hospital setting under general anesthesia (B01.003.004) for pain relief [236, 237, 238, 239].
GDR CLE 5Grade of recommendation C (level of evidence – 5)
It is recommended to conduct an initial examination (consultation) by an anesthesiologist-resuscitator (B01.003.001) before elective surgery no later than 24 hours prior to the planned scleroplasty to assess operational and anesthesiological risk, choose the anesthesia method, and perform preoperative preparation [236, 237, 238].
GDR CLE 5Grade of recommendation C (level of evidence – 5)
It is recommended to instill medicinal products into the conjunctival sac (A14.26.002) – antibiotic eye drops (S01AA) and corticosteroids (S01BA) in operated patients with myopia for 2 weeks after scleroplasty to prevent postoperative complications [217, 227, 239, 240].
GDR CLE 5Grade of recommendation C (level of evidence – 5)
It is not recommended to perform laser refractive surgery in children with myopia [67, 241].
GDR CLE 5Grade of recommendation C (level of evidence – 5)
Comments: no conclusive evidence of the efficacy and safety of laser refractive surgery in children with myopia has been found. The main factors limiting the use of laser refractive surgery in childhood include incomplete refractogenesis, irreversibility of the refractive effect, its instability, the need for general anesthesia (which makes it difficult to center the treatment zone along the visual axis), and a number of other issues.
Expanding the indications for refractive surgery in children is premature and unjustified. For the widespread use of laser correction in pediatric practice, many issues regarding effect stability, safety, efficacy, and impact on refractogenesis remain to be resolved. Careful long-term research in large research centers over – 10 years or more is necessary.
Keratorefractive interventions are performed in patients aged 18 to 45 years with non-progressive (stationary) myopia from -0.5 to -12.0 D to achieve a predictable and stable refractive effect and high postoperative uncorrected visual acuity. Keratorefractive surgeries are an alternative method of vision correction in adults alongside glasses and contact lenses and are performed at the patient's request. The choice of a specific technique (PRK, LASIK, LASEK, Epi-LASIK, FemtoLASIK, RelexFlex, RelexSmile) depends on the following parameters: patient age, profession, engagement in certain sports, preoperative anatomical and topographic corneal parameters, anatomical features of the eye and orbit structure, healing characteristics, and peripheral retinal status [242, 243, 244, 245, 246, 247].
Intraocular correction—IOL implantation, including phakic IOLs—is performed in patients over 18 years of age with myopia greater than -12.0 D in cases where other correction methods are inapplicable or yield a significantly poorer refractive and functional outcome. The method is used to correct high-degree refractive errors and achieve high uncorrected visual acuity after surgical intervention [248,249]. In high myopia combined with astigmatism greater than 3.0 D, bioptics (a combination of phakic IOL implantation and excimer laser correction) may be used. Phacoemulsification with intraocular lens implantation is advisable at the age of over 40 years, as well as in the presence of lens opacities.
4. Medical Rehabilitation and Sanatorium-Resort Treatment
It is recommended for the rehabilitation (B05.029.001) of children and adults with myopia and the optimization of refractogenesis: 1) prescribing a therapeutic and health-improving regimen for eye diseases (A25.26.003); 2) performing functional treatment; 3) performing exercises to train the ciliary muscle of the eye (A19.26.002) at home; 4) spa treatment (sanatorium-resort treatment) including therapeutic and health-improving measures, health-improving gymnastics, preferably in the fresh air, swimming (A19.30.008), functional treatment, training of the ciliary muscle of the eye, [19,66,67,123,188,190,198,203,204,250].
GRC CLEL 4Grade of Recommendation C (Level of Evidence – 4)
5. Prevention and Dispensary Observation
It is recommended to perform follow-up (dynamic observation) (B01.029.001, B01.029.002): every 6 months for progressive myopia in children and adults; once a year for stable myopia [96, 250].
CGR CLoE 5Level of Clinical Guidance Recommendation C (Level of Evidence – 5)
Comments: a decrease in the range of accommodation (ROA) below the minimum age-related values serves as a prognostic criterion for myopia progression. An increase in ROA values after treatment is a criterion for treatment efficacy and a favorable prognosis for the further course of myopia.
Detection of a positive accommodation reserve of more than 0.5 D in myopia is associated with a higher rate of myopia progression. A decrease in the accommodation reserve after treatment – is a criterion for treatment efficacy and a favorable prognosis for the further course of myopia [55].
Ultrasound criterion: Scleral acoustic density (SAD) – an informative indicator for predicting the nature of the further course of myopia, timely implementation of preventive measures, choice of treatment tactics, and indications for scleroplasty. SAD is evaluated by the amplitude of echo signal attenuation from the scleral capsule of the eye in the upper-temporal and lower-nasal quadrants of the equatorial zone and in the posterior pole of the eyeball.
- The normal SAD value for the equatorial zone is 46.0±0.24 dB;
- The normal SAD value in the region of the posterior pole of the eyeball is 47.6±0.2 dB;
- A decrease in SAD in myopia correlates with its degree, progression rate, and fundus condition;
- In eyes with uncomplicated myopia, the SAD in the equatorial zone is 40–48 dB;
- In eyes with myopia, an equator SAD of ≤ 39 dB is an unfavorable prognostic factor with a high probability of peripheral vitreochorioretinal degeneration (PVCRD) development;
- SAD measurement is used as an additional differential diagnostic study to select the method of scleral reinforcement: “major” or “minor” scleroplasty;
- Following “major” and “minor” scleroplasty, SAD increases: with “major” scleroplasty by 3.7 dB at the posterior pole and by 5.3 dB in the equatorial region; with “minor” scleroplasty, by 1.2 dB at the posterior pole and by 2.2 dB in the equatorial region. The change in SAD is statistically significant compared to the fellow eye and baseline level;
- In the long-term period after scleroplasty in eyes with continuing (or newly resumed) myopia progression, mean SAD values after both interventions not exceeding 41 dB at the posterior pole and 40 dB in the equatorial region serve as a criterion for the risk of further myopia progression and determination of indications for repeated scleral reinforcement [98,251].
It is recommended during an appointment (examination, consultation) with an ophthalmologist (B01.029.001, B01.029.002) for children and adults with myopia to evaluate the patient's complaints and medical history (A01.26.001), perform visometry (A02.26.004), autorefractometry with a narrow pupil (A12.26.016), refractometry (A03.26.008) under natural conditions and under cycloplegia and/or skiagraphy, determine refraction using a trial lens set (A02.26.013), perform eye biomicroscopy (A03.26.001), accommodation testing (A02.26.023), determination of the character of vision and heterophoria (A02.26.024), convergence testing (A02.26.026), determination of the AC/A ratio, eye mobility testing (A02.26.028), in concomitant strabismus—measurement of the angle of strabismus (A02.26.010), ultrasound examination of the eyeball (A04.26.002), ultrasound biometry of the eye (A04.26.004) or optical biometry of the eye (A05.26.007), determine the scleral acoustic density (SAD) (A12.26.017), perform ophthalmoscopy (A02.26.003), fundus biomicroscopy (A03.26.018), examination of the fundus periphery using a Goldmann three-mirror lens (A03.26.003), fundus biomicrophotography using a fundus camera (A03.26.005.001), localization of retinal tears (A03.26.017), and optical examination of the retina using a computer analyzer (A03.26.019) [1,96].
Level of Recommendation CLevel of Evidence 5Level of Recommendation C (Level of Evidence – 5)
No convincing evidence has been found regarding the use of dietary therapy for myopia in children and adults
6. Organization of Medical Care
Routine medical care is provided for myopia.
Primary pre-medical health care for adults with myopia is provided by medical opticians-optometrists.
Primary physician-delivered health care for children and adults with myopia is provided by ophthalmologists. An ophthalmologist at an ophthalmology office provides: consultative, diagnostic, and therapeutic care; dynamic observation; and, in the presence of medical indications, refers children to the children's vision protection office, and children and adults to specialized ophthalmological medical institutions and/or for inpatient medical care.
Upon suspicion or detection of signs of decreased vision in children and adults, pediatricians, district pediatricians, municipal (district) pediatricians, child and adolescent hygiene physicians, adolescent therapists, general practitioners (family doctors), district therapists, district occupational health therapists refer patients for a consultation with an ophthalmologist.
During routine medical examinations of minors, including upon admission to educational institutions and during the period of study, the ophthalmologist examines children at the age of 1 month, 12 months, 3 years, 6 years, 7 years, 10 years, 11 years, 15, 16, and 17 years.
The ophthalmologist examines adults with myopia during mandatory preliminary medical examinations (assessments) upon employment and periodic medical examinations (assessments) of workers engaged in work with harmful and (or) hazardous working conditions (including underground work), work related to the movement of transport, as well as workers of food industry organizations, public catering and trade, water supply facilities, medical organizations and childcare facilities, as well as certain other employers who undergo the specified medical examinations for the purpose of public health protection and the prevention of the occurrence and spread of diseases.
In the presence of progressive and/or complicated myopia, patients with myopia are referred for inpatient treatment to receive specialized medical care.
Indications for hospitalization in a day patient facility (day hospital) of a medical organization:
1) progressive myopia in children and adults, when indications for “minor” scleroplasty are identified and it cannot be performed in an outpatient setting;
2) progressive myopia in children and adults, when indications for functional treatment are identified and it cannot be performed in an outpatient setting;
3) complicated myopia in children and adults, when indications for laser barrier photocoagulation of the retina are identified and it cannot be performed in an outpatient setting;
Indications for hospitalization in a 24-hour inpatient facility (round-the-clock hospital) of a medical organization:
1) progressive myopia in children and adults, when indications for “major” scleroplasty are identified;
2) progressive myopia in children and adults, when indications for “minor” scleroplasty are identified and it cannot be performed in a day hospital or outpatient setting;
3) progressive myopia in children and adults, when indications for functional treatment are identified and it cannot be performed in an outpatient setting or in a day hospital setting;
4) complicated myopia in children and adults, when indications for laser barrier photocoagulation of the retina are identified and it cannot be performed in an outpatient setting or in a day hospital setting;
The basis for discharging a patient from a medical organization is the complete completion of the planned treatment.
7. Additional Information
Preventing the development of myopia is of particular importance, especially in preschool and early school age. Timely identification of myopia predictors [39,40,57] and active prevention of its early onset help reduce the incidence of high myopia and its complicated forms [39]. The most reliable predictors of myopia include: a cycloplegic spherical equivalent of axial refraction more hyperopic than +0.75 D in children under 6 years of age, an axial length greater than 23.5 mm with hyperopia $\le$+1.0 D, parental myopia, pseudomyopia, extra-axial refraction power of the nasal half of the eye at 20-30° higher than the temporal half in both eyes by more than 0.5 D, and physical inactivity combined with high visual workload [39,40,58,62,252]. Measures to prevent the early development of myopia include: compliance with the visual workload regimen—ergonomic stereotypes for near-vision work; creation of binocular central and peripheral myopic defocus—prescription of plus lenses inducing 0.75–1.0 D of myopia or transfocal spectacle lenses for vision correction with a central refraction of +0.25 D, the design of which allows them to be used for central vision correction and peripheral refractive reinforcement for continuous wear; home exercises for accommodation training, including the use of trainer glasses; physical education and sports; and spending at least 90 minutes a day outdoors during daylight hours [39,40,58,62,63,100,133,146,147,194,195,196,198].
Criteria for Evaluating the Quality of Medical Care
Criteria for assessing the quality of primary health care provided to children with myopia are presented in Table 7. Criteria for assessing the quality of specialized medical care provided to children with myopia are presented in Table 8. Criteria for assessing the quality of primary health care provided to adults with myopia are presented in Table 9. Criteria for assessing the quality of specialized medical care provided to adults with myopia are presented in Table 10.
Table 7. Criteria for assessing the quality of primary health care in children with myopia
No. | Quality assessment criteria | Performance evaluation |
|---|---|---|
1. | Initial appointment (examination, consultation) with an ophthalmologist was performed | Yes/no |
2. | Visometry performed (for patients aged 3 years and older) | Yes/no |
3. | Refraction determined using a trial lens set (under natural conditions) (for patients aged 3 years and older) | Yes/no |
4. | Accommodation study performed (for children aged 7 years and older) | Yes/no |
5. | Objective refraction measurement performed under cycloplegia | Yes/no |
6. | Ophthalmoscopy performed (under mydriasis) | Yes/no |
7. | Selection of spectacle correction and/or contact lens correction, and/or orthokeratology lenses performed | Yes/no |
Table 8. Criteria for assessing the quality of specialized medical care in children with myopia
No. | Quality assessment criteria | Performance evaluation |
|---|---|---|
1. | Visometry performed (for patients aged 3 years and older) | Yes/no |
2. | Refraction determined using a trial lens set (under natural conditions) (for patients aged 3 years and older) | Yes/no |
3. | Refractometry or autorefractometry performed with an un-dilated pupil | Yes/no |
4. | Ophthalmoscopy performed (under mydriasis) | Yes/no |
5. | Scleroplasty and/or sectoral laser photocoagulation of the retina, and/or medical rehabilitation services for a patient with visual system disorders performed | Yes/no |
Table 9. Criteria for assessing the quality of primary health care in adults with myopia
No. | Quality assessment criteria | Performance evaluation |
|---|---|---|
1. | Initial appointment (examination, consultation) with an ophthalmologist was performed | Yes/no |
2. | Visometry was performed | Yes/no |
3. | Determination of refraction using a trial lens set (under natural conditions) was performed | Yes/no |
4. | Refractometry or autorefractometry performed | Yes/no |
5. | Ophthalmoscopy performed (under mydriasis) | Yes/no |
6. | Selection of spectacle correction and/or contact lens correction, and/or orthokeratology lenses performed | Yes/no |
Table 10. Criteria for assessing the quality of specialized medical care in adults with myopia
No. | Quality assessment criteria | Performance evaluation |
|---|---|---|
1. | Visometry was performed | Yes/no |
2. | Refractometry or autorefractometry performed with an un-dilated pupil | Yes/no |
3. | Ophthalmoscopy performed (under mydriasis) | Yes/no |
4. | Scleroplasty and/or sectoral laser photocoagulation of the retina performed | Yes/no |
References
Show references
Avetisov E.S. Myopia / E.S. Avetisov. - M.: Meditsina, 1999. - 287 p.
Dolgin E. The myopia boom // Nature. – 2015.-Vol. 519, №7543.-P. 276–278. DOI:10.1038/519276a
Schaeffel F., Feldkaemper M. Animal models in myopia research // Clinical and Experimental Optometry. – 2015.-Vol.98,№6.-Р. 507–517. DOI:10.1111/ cxo.12312
Report on experimental models of emmetropization and myopia / D. Troilo, E.L. Smith 3rd, D.L.Nickla,D L. Nickla, R. Ashby; A.V. Tkatchenko, L. A. Ostrin, T, J. Gawne, M. T. Pardue, J. A. Summers, C. Kee, F. Schroedl, S. Wahl, L. Jones // Invest. Ophthalmol. Vis. Sci. – 2019. - Vol.60, №3.-Р. M31–M88. DOI:10.1167/iovs.18-25967
Wallman J., Winawer J. Homeostasis of eye growth and the question of myopia // Neuron. – 2004.-Vol.43, №4. – P. 447–68. DOI:10.1016/j.neuron.2004.08.008
Nickla D.L., Wallman J. The multifunctional choroid // Progress in retinal and eye research. - 2010.-Vol.29, №2.-Р. 144–68. DOI:10.1016/j.preteyeres.2009.12.002
Harper A.R., Summers J.A. The dynamic sclera: extracellular matrix remodeling in normal ocular growth and myopia development // Exp. Eye Res. – 2015.- Vol.133.- P 100–111. DOI:10.1016/j.exer.2014.07.015
Hemi-retinal form deprivation: evidence for local control of eye growth and refractive development in infant monkeys/E. L. Smith 3rd, J. Huang, Li-F. Hung, T. L. Blasdel, T. L. Humbird, K. H. Bockhorst // Invest. Ophthalmol. Vis. Sci. – 2009.- Vol.50, №11.- P. 5057–5069. DOI:10.1167/iovs.08-3232
Effects of optical defocus on refractive development in monkeys: evidence for local, regionally selective mechanisms/ E. L. Smith 3rd, Li-F. Hung, J. Huang, T. L. Blasdel, T. L. Humbird, K. H. Bockhorst //Invest. Ophthalmol. Vis. Sci. – 2010 .- Vol. 51, № 8.- P. 3864–3873. DOI:10.1167/iovs.09-4969
Smith E.L. 3rd. Prentice award lecture 2010: A case for peripheral optical treatment strategies for myopia //Optom. Vis. Sci. 2011. - Vol. 88, № 9. – P. 1029–1044. DOI:10.1097/opx.0b013e3182279cfa
A strategically oriented concept for the optical prevention of the onset and progression of myopia / E.P. Tarutta, O.V. Proskurina, G.A. Markosyan, S.V. Milash, N.A. Tarasova, N.V. Khodjabekyan // Russian Ophthalmological Journal. – 2020.- Vol.13, № 4.- P.7-16. DOI:10.21516/2072-0076-2020-13-4-7-16
Avetisov E.S. Current state of research on the etiology and pathogenesis of myopia // Annals of Ophthalmology. – 1967.- Vol. 80, №5.- P. 38–45.
Davies L.N., Mallen E.A. Influence of accommodation and refractive status on the peripheral refractive profile // The British journal of ophthalmology. – 2009.- Vol. 93, № 9.- Р. 1186–90. DOI:10.1136/bjo.2009.159053
Lundström L., Mira-Agudelo A., Artal P. Peripheral optical errors and their change with accommodation differ between emmetropic and myopic eyes // Journal of vision. – 2009.- Vol. 9, № 6.- P. 1–11. DOI:10.1167/9.6.17
Influence of accommodation on off-axis refractive errors in myopic eyes /A. Whatham, F. Zimmermann, A. Martinez, S. Delgado, P. Lazon de la Jara, P. Sankaridurg, A. Ho. // Journal of Vision. – 2009. - Vol. 9,№ 3 (14).- P. 1–13. DOI:10.1167/9.3.14
Charman W.N., Radhakrishnan H. Peripheral refraction and the development of refractive error: a review // Ophthalmic and Physiological Optics. – 2010.- Vol. 30, № 4.- P.321–38. DOI:10.1111/j.1475-1313.2010.00746.x
Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050 / B.A. Holden, T.R. Fricke, D.A. Wilson, M. Jong, K.S. Naidoo, P. Sankaridurg, T.Y. Wong, T.J. Naduvilath, S. Resnikoff // Ophthalmology. – 2016.- Vol.123, №5.- P.1036-1042. DOI: 10.1016/j.ophtha.2016.01.006. Epub 2016 Feb 11.
Increasing prevalence of myopia in Europe and the impact of education / K.M. Williams, G. Bertelsen, P. Cumberland, C. Wolfram, V.J. Verhoeven, E. Anastasopoulos, et al.// Ophthalmology.- 2015.- Vol.122, №7.- P. 1489–1497. DOI:10.1016/j.ophtha.2015.03.018
A comprehensive approach to the prevention and treatment of progressive myopia in schoolchildren / E.P. Tarutta, E.N. Iomdina, N.A. Tarasova, G.A. Markosyan, M.V. Maksimova // RMJ. Clinical Ophthalmology. - 2018.- №2.- P. 70-76.
Prevalence of myopia in schoolchildren in certain regions of Russia / O.V. Proskurina., E.Yu. Markova, V.V. Brzhesky, E.L. Efimova, M.N. Efimova, N.V. Khvatova N.N. Slyshalova, A.V. Egorova // Ophthalmology.- 2018.- Vol.15, №3.- P.348– 353. DOI:10.18008/1816-5095-2018-3-348-353
Highprevalenceofmyopiaandhighmyopiain 5060 ChineseuniversitystudentsinShanghai / J. Sun, J. Zhou, P. Zhao, J. Lian, H. Zhu, Y. Zhou, Y. Sun, Y. Wang, L. Zhao, Y. Wei, L. Wang, B. Cun, S. Ge, X. Fan // Invest. Ophthalmol. Vis. Sci.- 2012.-Vol. 53, №12.- P. 7504– 7509. DOI: 10.1167/iovs.11-8343.
Prevalence of myopia and its association with body stature and educational level in 19-year-old male conscripts in Seoul, South Korea / S.K. Jung, J.H. Lee, H. Kakizaki, D. Jee// Invest. Ophthalmol. Vis. Sci.- 2012.- Vol.53, №9.- P. 5579–5583. DOI: 10.1167/iovs.12-10106.
The age-specific prevalence of myopia in Asia: a meta-analysis / C.W. Pan, M. Dirani, C.Y. Cheng, T.Y. Wong, S.M. Saw // Optom Vis Sci. – 2015.- Vol. 92, № 3.- P. 258–66. DOI:10.1097/OPX.0000000000000516
Prevalence and associated factors of myopia in highschool students in Beijing / L.J. Wu, Q.S. You, J.L. Duan, Y.X. Luo, L.J. Liu, X. Li, Q. Gao, H.P. Zhu, Y. He, L. Xu, J.B. Jonas, W. Wang, X.H. Guo // PLoS One.- 2015.- Vol.10, №3:e0120764. URL: /https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0120764. DOI: 10.1371/journal. pone.0120764. eCollection 2015
Prevalence of myopia in the United States / R.D. Sperduto, D. Seigel, J. Roberts, M. Rowland // Arch Ophthalmol. – 1983.-Vol. 101,№ 3.- P. 405–407.
Vitale S., Sperduto R.D., Ferris F.L., 3rd. Increased prevalence of myopia in the United States between 1971–1972 and 1999–2004 // Arch. Ophthalmol.- 2009.- Vol. 127, № 12.- P. 6321639. DOI: 10.1001/archophthalmol.2009.303
Prevalence of myopia and its risk factors in urban school children in Delhi: the North India Myopia Study (NIM Study) / R. Saxena, P. Vashist, R. Tandon, R.M. Pandey, A. Bhardawaj, V. Menon, K. Mani // PLoS One.- 2015.- Vol.10, № 2.-:e0117349. URL:/https://www.researchgate.net/publication/272836803_Prevalence_of_Myopia_and_Its_Risk_Factors_in_Urban_School_Children_in_Delhi_The_North_India_Myopia_Study_NIM_Study DOI: 10.1371/journal.pone.0117349. eCollection 2015
Pärssinen O. The increased prevalence of myopia in Finland // Acta. Ophthalmol.- 2012.- Vol;. 90, № 6.- P. 497–502. DOI: 10.1111/j.1755-3768.2011.02210.x.Epub 2011 Sep 8.
IMI - defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies / D. I. Flitcroft, M.He, J. B. Jonas, M. Jong , K. Naidoo, K. Ohno-Matsui, J. Rahi, S. Resnikoff, S. Vitale, L. Yannuzzi // Invest. Ophthalmol. Vis. Sci. -2019.- Vol. 60, № 3.- P.M20–M30 DOI: 10.1167/iovs.18-25957
Tron E. Uber die optischen Grundlagen der Ametropie // Graefes Arch. Ophthalmol.– 1934.- № 132.- P. 182-223.DOI: 10.1007/BF01853824
Tron E.Zh. Variability of the elements of the optical apparatus of the eye and its clinical significance / E.Zh. Tron.- L.: Publishing House of the Military Medical Academy, 1945.-272p.
Jones W.L. Peripheral ocular fundus / W.L. Jones.- London: Butterworth-Heinemann, 2017 – 288 p.
International photographic classification and grading system for myopic maculopathy / K. Ohno-Matsui, R. Kawasaki , J. B. Jonas, C. M. G. Cheung , S.-M. Saw, V. J. M. Verhoeven, C. C. W. Klaver, M. Moriyama, K. Shinohara, Y. Kawasaki, M. Yamazaki, S. Meuer, T. Ishibashi, M. Yasuda, H. Yamashita, A. Sugano, J. J. Wang, P. Mitchell, T. Y. Wong, META-analysis for Pathologic Myopia (META-PM) Study Group // Am. J. Ophthalmol. – 2015.- Vol. 159, №5.- Р.877–883. DOI: 10.1016/j.ajo.2015.01.022
Myopic maculopathy: Current status and proposal for a new classification and grading system (ATN) / J. Ruiz-Medrano, J.A. Montero, I. Flores-Moreno, L. Arias,A. García-Layana,J.M. Ruiz-Moreno //Prog.Retin. Eye Res. – 2019. – Vol. 69.- P. 80-115. DOI:10.1016/j.preteyeres.2018.10.005.
Wojciechowski R. Nature and nurture: the complex genetics of myopia and refractive error //Clin. Genet.- 2011.- Vol. 79, №4.-P. 301–320. DOI: 10.1111 / j.1399-0004.2010.01592.x
Early childhood refractive error and parental history of myopia as predictors of myopia / L. A. Jones-Jordan, L. T. Sinnott, R. E. Manny, S. A. Cotter, R. N. Kleinstein, D. O Mutti, J. D. Twelker, K. Zadnik and CLEERE Study Group // Invest. Ophthalmol. Vis. Sci. – 2010.- Vol. 51,№1 .-P.115– 121. DOI: 10.1167/iovs.08-3210
Wu M.M., Edwards M.H. The effect of having myopic parents: an analysis of myopia in three generations//Optom. Vis Sci. – 1999.- Vol.76, №6.- P. 387–392
The effect of parental history of myopia on children"s eye size / K. Zadnik, W.A. Satariano, D.O. Mutti, R.I. Sholtz, A.J. Adams// JAMA.- 1994.-Vol. 271, №17.- P.1323-1327
Analysis of risk factors for the development of nearsightedness in preschool and early school age / E.P. Tarutta, O.V. Proskurina, N.A. Tarasova, G.A. Markosyan // Health Risk Analysis. – 2019. – № 3. – P. 26–33. DOI: 10.21668/health.risk/2019.3.03
Predictors of myopia as a starting point for initiating active measures to prevent its development / E.P. Tarutta, O.V. Proskurina, N.A. Tarasova, R.A. Ibatulin, A.S. Kovychev // Russian Ophthalmological Journal. -2018.-Vol.11, №3.- P.107-112. DOI: 10.21516/2072-0076-2018-11-3-107-112
Serdyuchenko V.I. Dragomiretskaya E.I. Nostopyreva I.I. Somatic status and physical development of children and adolescents as risk factors for the development of myopia // Ophthalmological Journal.- 1998.-№2.-P.23-25.
Chetyz R.R., Soboleva L.K. The role of systemic disorders in children in the onset of nearsightedness // Advances in Modern Natural Sciences.- 2004.-Vol.16, №27. - P. 101
Tarutta E.P. Complicated nearsightedness. Issues of pathogenesis, clinical presentation, treatment, and prevention. In: Neroev V.V., ed. Selected lectures on pediatric ophthalmology. - M.: Geotar-Media; 2009.- P. 102-125.
Avetisov E.S., Tarutta E.P. Complicated myopia. In: Shamshinova A.M. ed. Hereditary and congenital diseases of the retina and optic nerve.- M.: Medicine; 2001. – P.151-172
Curtin B.J., Karlin D.B. Axial length measurements and fundus changes of the myopic eye // Am. J. Ophthalmol. – 1971.-Vol. 7, № 1.-Р. 42-53. DOI: 10.1016/0002-9394(71)91092-0.
Curtin B.J. The myopias: basic science and clinical management / B. J. Curtin. - Philadelphia: Harper and Row, 1985.-495 p.
Fundus characteristics of high myopia in children / K. Kobayashi, K Ohno-Matsui, A. Kojima, N. Shimada, K. Yasuzumi, T. Yoshida, S. Futagami, T. Tokoro, M. Mochizuki // Jpn. J. Ophthalmol. – 2005. – Vol. 49, № 4. – P. 306-311. DOI: 10.1007/s10384-004-0204-6
Myopia-related optic disc and retinal changes in adolescent children from Singapore / C. Samarawickrama, P. Mitchell, L. Tong, G. Gazzard, L. Lim, T.-Y. Wong, S.-M. Saw // Ophthalmology. – 2011. – Vol. 118, №10. – P. 2050-2057 DOI: 10.1016/j.ophtha.2011.02.040
Long-term pattern of progression of myopic maculopathy: a natural history study / K. Hayashi, K. Ohno-Matsui, N. Shimada, M. Moriyama, A. Kojima, W. Hayashi, K. Yasuzumi, N. Nagaoka, N. Saka, T. Yoshida, T. Tokoro, M Mochizuki // Ophthalmology. – 2010.-Vol.117, № 8.-Р.1595-1611.e16114. DOI:10.1016/j.ophtha.2009.11.003
Avetisov E.S. The role of scleral stretching in the genesis of myopic vitreochorioretinal dystrophies / E.S. Avetisov, E.P. Tarutta, F.E. Fridman, E.O. Saksonova // Ophthalmological Journal .- 1988.- №3.- P.21-24
Avetisov E.S., Flik L.P. Features of fundus changes in high nearsightedness // Annals of Ophthalmology.- 1974.- №2.- P. 8-12.
Saksonova E.O., Eliseeva R.F., Nesterov S.A. On the classification of peripheral vitreochorioretinal dystrophies // Proceedings of the V All-Union Congress of Ophthalmologists. - M., 1979.- Vol.3.- P. 106–108
Tarutta E.P., Saksonova E.O. The state of the peripheral fundus in high progressive nearsightedness // Annals of Ophthalmology. – 1991. – № 1. – P. 54-58
Bayer E.N. Peripheral retinal lesions to rhegmatogenous retinal detachment // Retina-Vitreous-Macula.- Philadelphia: Saunder’s Company, 1999.- P. 1219-1248
Tarutta E.P. Complicated nearsightedness: congenital and acquired // Visual functions and their correction in children / In: S.E. Avetisov, T.P. Kashchenko, A.M. Shamshinova.-M.: Medicine, 2005.-P.137-162.
Tarutta E.P., Tarasova N.A. Accommodation tone in myopia and its potential prognostic value // Annals of Ophthalmology.- 2012.-№ 2.-P. 34-37.
Panteleeva O.A., Tarutta E.P., Markosyan G.A. Hereditary factors in the development of myopia // Russian Ophthalmological Journal.- 2009.- № 3.- P. 48-50
Prediction of juvenile-onset myopia /K. Zadnik, L.T. Sinnott, S.A. Cotter, L.A. Jones-Jordan, R.N. Kleinstein, R.E. Manny, J.D. Twelker, D.O. Mutti and CLEERE Study Group // JAMA Ophthalmol. – 2015.- Vol. 133,№ 6.- P. 683–689. DOI:10.1001 / jamaophthalmol.2015.0471
Myopia management algorithm. Annexe to the article titled Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute / B. Tapasztó, D.I. Flitcroft, W.A. Aclimandos, J.B. Jonas, J.H.N. De Faber, Z.Z. Nagy, P.G. Kestelyn, I. Januleviciene, A. Grzybowski, C.N. Vidinova, J.A. Guggenheim, J.R. Polling, J.S. Wolffsohn, J.W.L. Tideman, P.M. Allen, R.C. Baraas, K.J. Saunders, S.J. McCullough, L.S. Gray, S. Wahl, I.Y. Smirnova, M. Formenti, H. Radhakrishnan, S. Resnikoff, J. Németh, SOE Myopia Consensus Group // Eur. J. Ophthalmol. – 2023. – № 12. – P. 1-15. DOI: 10.1177/11206721231219532.
The Cambridge Anti-myopia study: variables associated with myopia progression / N. Price, P.M. Allen, H. Radhakrishnan, R. Calver, S. Rae, B. Theagarayan, A. Sailoganathan, D.J. O'Leary // Optom Vis Sci. – 2013. – Vol. 90, № 11. – P. 1274–1283. DOI: 10.1097/OPX.0000000000000067
Near work related parameters and myopia in Chinese children: the Anyang childhood eye Study / S.M. Li, S.Y. Li, M.-T. Kang, Y. Zhou, L.-R. Liu, H. Li, Y.-P. Wang, S.-Y. Zhan, B. Gopinath, P. Mitchell, N. Wang // PLoS One. – 2015. – № 10: e0134514. DOI: 10.1371/journal.pone.0134514
Time spent in outdoor activities in relation to myopia prevention and control: a meta‐analysisand systematic review / S. Xiong, P. Sankaridurg, T. Naduvilath, J. Zang, H. Zou, J. Zhu, M. Lv, X. He, X. Xu // ActaOphthalmol. – 2017.-Vol. 95, № 6.-P. 551–566. DOI: 10.1111/aos.13403
The association between time spent outdoors and myopia in children and adolescents: A systematic review and meta‐analysis / J.C. Sherwin, M.H. Reacher, R.H. Keogh, A.P. Khawaja, D.A. MacKey, P.J. Foster // Ophthalmology.- 2012.- Vol. 119,№ 10.- P. 2141–2151. DOI: 10.1016/j.ophtha.2012.04.020.
Biomechanical parameters of the corneoscleral shell of the eye and the state of the connective tissue system in children and adolescents with various forms of progressive myopia / E.N. Iomdina, E.P. Tarutta, G.A. Markosyan, Yu.M. Aksenova, G.V. Kruzhkova, Zh.N. Ivashchenko, T.S. Smirnova, A.N. Bedretdinov // Rossiyskaya Pediatricheskaya Oftalmologiya. – 2013. – № 1. – P. 18-23.
Iomdina E.N. Biomechanical and biochemical disorders of the sclera in progressive myopia and methods for their correction // Visual functions and their correction in children / In: S.E. Avetisov, T.P. Kashchenko, A.M. Shamshinova. – M.: Meditsina, 2005. – P. 163-183.
Rosenblum Yu.Z. Funktsionalno-vozrastnoy podkhod k kompensatsii ametropii // Vestn. oftalmol. - 2004.- № 1.- P. 51-56
Tarutta E.P. Progressive and complicated myopia. In: Pediatrics. National Guidelines. Vol. 2. M.: Goetar-Media, 2009. – P. 816-822.
Rosenblum Yu.Z. Optometry / Yu.Z. Rosenblum. - St. Petersburg: Hippocrates, 1996.-247 p.
RosnerJ. Pediatricoptometry/J. Rosner.-Boston,London: Butterworths, 1982.- P.36-67.
Rosenblum Yu.Z., Proskurina O.V. Visual acuity, refraction, and accommodation in children // Visual functions and their correction in children / In: S.E. Avetisov, T.P. Kashchenko, A.M. Shamshinova. – M.: Meditsina, 2005. – P. 38-65.
Proskurina O.V. Static and dynamic retinoscopy (skiascopy) // Vestnik Optometrii. – 2012. – № 5. – P. 44-46.
Rosenblum Yu.Z., Proskurina O.V. Use of automatic refractometers in the practice of an ophthalmologist and optometrist // Vestnik Optometrii. – 2001. – № 5. – P. 9-17.
Proskurina O.V. Cycloplegic efficacy of cyclopentolate and tropicamide preparations compared to atropinization // Vestnik Oftalmologii. – 2002. – № 6. – P. 45-48.
Express-cycloplegia in children with myopia. Objectification of choice / R.V. Ershova, V.V. Brzheskiy, V.O. Sokolov, E.A. Kravchenko // Rossiyskaya Detskaya Oftalmologiya. – 2016. – № 2. – P. 30-37.
Comparison of cyclopentolate versus tropicamidecycloplegia: A systematic review and meta-analysis. / N. Yazdani, R. Sadeghi, H. Momeni-Moghaddam, L. Zarifmahmoudi, A. Ehsaei // J. Optom. – 2017.- Vol.11,№3.- P.135-143. DOI: 10.1016/j.optom.2017.09.001. Epub 2017 Nov 11
Atchison D.A., Mathur A., Varnas S.R. Visual performance with lenses correcting peripheral refractive errors // Optom. Vis. Sci. – 2013. – Vol. 90, № 11. – P. 1304-1311. DOI: 10.1097/OPX.0000000000000033
Troilo D., Wallman J. The regulation of eye growth and refractive state: An experimental study of emmetropization // Vis. Res. – 1991. – Vol. 31, № 7-8. – P. 1237-1250.
Refractive error, axial length, and relative peripheral refractive error before and after the onset of myopia / D.O. Mutti, J.R. Hayes, G.L. Mitchell, L.A. Jones, M.L. Moeschberger, S.A. Cotter, R.N. Kleinstein, R.E. Manny, J.D. Twelker // Invest. Ophthalmol. Vis. Sci. – 2007. – Vol. 48, № 6. – P. 2510–2519.
The effect of multifocal soft contact lenses on peripheral refraction / R. Kang, Y. Fan, K. Oh, K. Trac, F. Zhang, H.A. Swarbrick // Optom. Vis. Sci. – 2013. – Vol. 90, № 7. – P. 658-666. DOI: 10.1097/OPX.0b013e3182990878
Peripheral refraction and retinal contour in children with myopia based on refractometry and partial coherence interferometry / E.P. Tarutta, S.V. Milash, N.A. Tarasova, L.I. Romanova, G.A. Markosyan, M.V. Epishina // Vestnik Oftalmologii. – 2014. – Vol. 160, № 6. – P. 44-49.
Peripheral defocus of myopic eyes during correction with perifocal, monofocal glasses, and soft contact lenses / E.P. Tarutta, N.A. Tarasova, O.V. Proskurina, S.V. Milash, N.Yu. Kushnarevich, N.V. Khodjabekyan // Rossiyskiy Oftalmologicheskiy Zhurnal. – 2018. – Vol. 11, № 4. – P. 36-42. DOI: 10.21516/2072-0076-2018-11-4-36-41
Peripheral vision can influence eye growth and refractive development in infant monkeys / E.L. Smith, C.S. Kee, R. Ramamirtham, Y. Qiao-Grider, L.F. Hung // Invest. Ophthalmol. Vis. Sci. – 2005. – Vol. 46, № 11. – P. 3965-3972.
Tarutta E.P., Tarasova N.A. Comparative evaluation of the efficacy of subjective and objective methods for determining addition when prescribing progressive glasses to children // Sovremennaya Optometriya. – 2011. – № 9. – P. 40-44.
Kornyushina T.A. Features of accommodation changes in children with various types of refraction under the influence of visual load // Rossiyskaya Detskaya Oftalmologiya. – 2014. – № 2. – P. 26-33.
Proskurina O.V., Golubev S.Yu., Markova E.Yu. Subjective methods for studying accommodation. In: Katargina L.A., ed. Accommodation. Guidelines for physicians. – M.: Aprel, 2012. – P. 40-49.
Proskurina O.V. Presbyopia: modern approach to spectacle correction (part 1) // Rossiyskiy Oftalmologicheskiy Zhurnal. – 2009. – № 1. – P. 49-54.
Proskurina O.V. Presbyopia: modern approach to spectacle correction (part 2) // Rossiyskiy Oftalmologicheskiy Zhurnal. – 2009. – № 2. – P. 52-55.
Tarutta E.P., Filinova O.B., Tarasova N.A. New methods of objective accommodometry // Russian Pediatric Ophthalmology. - 2012. - No. 1. - P. 45-48.
Tarutta E.P. Objective accommodometry. In: Katargina L.A., ed. Accommodation. Guidelines for physicians. – M.: Aprel, 2012. – P. 50-62.
Zhukova O.V., Egorova A.V. Computer accommodography. In: Katargina L.A., ed. Accommodation. Guidelines for physicians. – M.: Aprel, 2012. – P. 63-66.
Proskurina O.V. Dynamic retinoscopy (skiascopy). In: Katargina L.A., ed. Accommodation. Guidelines for physicians. – M.: Aprel, 2012. – P. 67-74.
Ershova R.V., Brzheskiy V.V., Sokolov V.O. Capabilities of computer accommodography in examining children with various types of clinical refraction (preliminary report) // Detskaya Oftalmologiya. – 2010. – Vol. 3, № 3. – P. 34-39.
GwiazdaJ., ThornF., HeldR. Accommodation, accommodativeconvergence, andresponseAC/Aratiosbeforeandattheonsetofmyopia in children // Optom. Vis. Sci. – 2005.- Vol.82, №34.- P.273-278. DOI:10.1097/01.opx.0000159363.07082.7d.
Gwiazda J., Grice K, Thorn F. Response AC/A ratios are elevated in myopic children // Ophthalmic Physiol. Opt. – 1999.- Vol.19,№2.- P. 173-179. DOI:10.1046/j.1475-1313.1999.00437.x.
Scheiman M., Wick B. Clinical Management of Binocular Vision: Heterophoric, Accommodative, and Eye Movement Disorders / M. Scheiman, B. Wick. – Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins, 2014. – 748 p.
Clinical management guidelines report / K.L. Gifford, K. Richdale, P. Kang, T.A. Aller, C.S. Lam, Y.M. Liu, L. Michaud, J. Mulder, J.B. Orr, K.A. Rose, K.J. Saunders, D. Seidel, J.W.L. Tideman, P. Sankaridurg // Invest. Ophthalmol. Vis. Sci. – 2019.- Vol.60, N 3.- P. 184–203. DOI: 10.1167/iovs.18-25977
IMI Accommodation and binocular vision in myopia development and progression / N.S. Logan, H. Radhakrishnan, F.E. Cruickshank, P.M. Allen, P.K. Bandela, L.N. Davies, S. Hasebe, S. Khanal, K.L. Schmid, F.A. Vera-Diaz, J.S. Wolffsohn // Invest. Ophthalmol. Vis. Sci. – 2021.- Vol. 28,№5.- P. 4. DOI: 10.1167/iovs.62.5.4.
Scleral acoustic density as a prognostic factor for the development of peripheral vitreochorioretinal degeneration in myopia: results of a 10-year follow-up / E.P. Tarutta, M.V. Maksimova, G.V. Kruzhkova, N.V. Khodjabekyan, G.A. Markosyan // Vestnik Oftalmologii. – 2013. – № 1. – P. 16-20.
Acoustic studies of the sclera in progressive myopia in children and adolescents / E.S. Avetisov, F.E. Fridman, E.P. Tarutta, G.V. Kruzhkova, N.V. Khodjabekyan // Vestnik Oftalmologii. – 1996. – Vol. 112, № 2. – P. 41-43.
Effect of constant low-myopic defocus in binocular and monocular alternating spectacle format on the course of myopia in children / E.P. Tarutta, N.V. Khodjabekyan, O.B. Filinova, S.V. Milash, G.V. Kruzhkova // Rossiyskaya Pediatricheskaya Oftalmologiya. – 2016. – Vol. 11, № 2. – P. 82-88. DOI: 10.18821/1993-1859-2016-11-2-82-88
Dynamics of peripheral refraction and eye shape during orthokeratology lens wear in children with progressive myopia / E.P. Tarutta, E.N. Iomdina, R.R. Toloraya, G.V. Kruzhkova // Rossiyskiy Oftalmologicheskiy Zhurnal. – 2016. – Vol. 9, № 1. – P. 62-66. DOI: 10.21516/2072-0076-2016-9-1-62-66
Avetisov E.S., Tarutta E.P. A new surgical procedure for myopia and its results // Vestnik Oftalmologii. – 1981. – № 3. – P. 21-24.
Defocusincorporatedmultiplesegments (DIMS) spectaclelensesslowmyopiaprogression: a 2-yearrandomisedclinicaltrial / C.S.Y. Lam, W.C. Tang, D.Y. Tse, R. P. K. Lee, R. K. M. Chun, K. Hasegawa, H. Qi, T. Hatanaka, C. H. To //Br. J. Ophthalmol. -2020.- Vol. 104, № 3.- P. 363-368. DOI:10.1136/bjophthalmol-2018-313739
Svirin A.V., Antipova O.A. Long-term results of allotissue administration into Tenon's space in progressive myopia // Oftalmologicheskiy Zhurnal. – 1984. – № 8. – P. 471-472.
Svirin A.V., Batmanov Yu.E., Nesterov A.N., Serebryakova T.V. Two-dimensional echography in the study of eyes with myopia // Vestnik Oftalmologii. – 1982. – № 5. – P. 40-42.
Mydriasis with micro-array print touch-free tropicamide-phenylephrine fixed combination MIST: pooled randomized Phase III trials / D.L. Wirta, T.R. Walters, W.J. Flynn, S. Rathi, T. Ianchulev // Ther Deliv. – 2021.- Vol. 12, № 3.- P. 201-214. DOI: 10.4155/tde-2021-0011
Pupil dilation evaluation of two mydriatic dosing profiles delivered by the Optejet®/ A. Chayet, A. Ramirez, B. Scott, J. Whitcomb, P. Lam, T. Ianchulev // Ther Deliv. – 2023.- Vol. 14,№2.- P. 93-103. DOI: 10.4155/tde-2022-0061.
Kergoat H., Lovasik J.V., Doughty M.J. A pupillographic evaluation of a phenylephrine HCl 5%-tropicamide 0.8% combination mydriatic // J. Ocul. Pharmacol. – 1989.- Vol. 5, №3.- P.199-216. DOI: 10.1089/jop.1989.5.199. PMID: 2625616.
Ward B., Tarutta E. Degenerative myopia: an “algorithm” for its treatment in adolescents // 2nd World Congress of Pediatric Ophthalmology and Strabismus (WCPOS). – Milan, 2012. – P. 233.
Peripheral vitreochorioretinal degenerations in patients with myopia / V.V. Ilnitskiy, E.O. Saksonova, N.V. Guryeva, N. Georgiev, L.M. Balashova // Vestnik Oftalmologii. – 1993. – Vol. 109, № 4. – P. 18-20.
Association of axial length with risk of uncorrectable visual impairment for Europeans with myopia / J.W.L. Tideman, M.C.C. Snabel, M.S. Tedja, G.A. van Rijn, K.T. Wong, R.W.A.M. Kuijpers, J.R. Vingerling, A. Hofman, G.H.S. Buitendijk, J.E.E. Keunen, C.J.F. Boon, A.J.M. Geerards, G.P.M. Luyten, V.J.M. Verhoeven, C.C.W. Klaver // JAMA Ophthalmol. – 2016. – Vol. 134, № 12. – P. 1355–1363. DOI: 10.1001/jamaophthalmol.2016.4009
Visual consequences of refractive errors in the general population / V.J.M. Verhoeven, K.T. Wong, G.H. Buitendijk, A. Hofman, J.R. Vingerling, C.C. Klaver // Ophthalmology. – 2015. – Vol. 122, № 1. – P. 101–109. DOI: 10.1016/j.ophtha.2014.07.030
Scheiman M., Wick B. Clinical Management of Binocular Vision: Heterophoric, Accommodative, and Eye Movement Disorders / M. Scheiman, B. Wick. – Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins, 2014. – 748 p.
Jethani J., Solanki H., Nayak A. Effect of the single-drop mydriatic combination of 0.8% tropicamide with 5% phenylephrine with multiple applications of the same drop: a randomized controlled trial // Indian Journal of Ophthalmology. -2011. -Vol. 59, № 4.-323-325. DOI:10.4103/0301-4738.82008
Vorontsova T.N., Somov E.E., Kononova N.E. [Once again on the clinical features and treatment of children with peripheral retinal degeneration]. Rossiyskaya detskaya oftalmologiya [Russian Children's Ophthalmology]. 2022;3:21–26. (In Russ.). DOI: 10.25276/2307-6658-2022-3-21-26.
Strakhov V.V., Gulidova E.G. [Features of myopia progression depending on the level of ophthalmotonus]. Rossiyskaya pediatricheskaya oftalmologiya [Russian Pediatric Ophthalmology]. 2011;1:15-19. (In Russ.).
Strakhov V.V., Gulidova E.G., Alekseev V.V. [Features of the course and monitoring of progressive myopia depending on ophthalmotonus]. Rossiyskiy oftalmologicheskiy zhurnal [Russian Ophthalmological Journal]. 2013;6(2):76-81. (In Russ.).
Intraocular pressure and glaucomatous optic neuropathy in high myopia / J.B. Jonas, N. Nagaoka, Y.X. Fang, P. Weber, K. Ohno-Matsui // Invest. Ophthalmol. Vis. Sci. – 2017.- Vol. 58, № 13.- P.5897-5906. DOI: 10.1167/iovs.17-21942
Myopia as a risk factor for open-angle glaucoma: a systematic review and meta-analysis /M. W. Marcus, M.M. de Vries, F.G. J.Montolio, N.M. Jansonius // Ophthalmology. – 2011.- Vol. 118, № 10 .- P, 1989–1994.e2.: DOI: 10.1016/j.ophtha.2011.03.012
Karlova E.V., Zolotarev A.V., Milyudin E.S., Pershakova A.E. [Transpalpebral tonometry in patients after penetrating keratoplasty]. Klinicheskaya oftalmologiya [Clinical Ophthalmology]. 2020;20(4):175-179. (In Russ.). DOI: 10.32364/2311-7729-2020-20-4-175-179.
Iomdina E.N., Kushnarevich N. Yu. Possibilities of monitoring intraocular pressure in children using EASYTON transpalpebral tonometer // International Ophthalmology.- 2022.- Vol. 42, № 5.- P. 1631-1638. DOI: 10.1007/s10792-021-02158-5.
Proskurina O.V. [Accommodation tone in children]. Refraktsionnaya khirurgiya i oftalmologiya [Refractive Surgery and Ophthalmology]. 2004;2(4):16-19. (In Russ.)
Myopia correction in children: meta-analysis / Y. Cui, L. Li, Q. Wu, J. Zhao, H. Chu, G. Yu, W. Wei // Clin.Invest.Med.- 2017.- Vol. 40, № 3 .- P 117-126
Spectacle lenses designed to reduce progression of myopia: 12-month results / P. Sankaridurg, L. Donovan, S. Varnas, A. Ho, X. Chen, A. Martinez, S. Fisher, Z. Lin, E.L. Smith3rd, J. Ge, B. Holden //Optom Vis Sci. - 2010.- Vol. 87, №9.- P. 631-641. DOI: 10.1097/OPX.0b013e3181ea19c7.
Bao J, Yang A, Huang Y. et al. One-year myopia control efficacy of spectacle lenses with aspherical lenslets. Br. J. Ophthalmol. 2021; 0:1–6. https://doi:10.1136/bjophthalmol-2020-318367
Bao J., Huang Y., Li X. et al. Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses. A randomized clinical trial. JAMA Ophthalmol. 2022. doi:10.1001/jamaophthalmol.2022.0401
Lam C.S., Tang W.C., Lee P.H., et al. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study / C.S.Y. Lam, W. C. Tang, P. H. Lee, H. Y. Zhang, H. Qi, K. Hasegawa, C. H. To // Br. J. Ophthalmol. - 2021. - Vol.106, №8. – P. 1110 - 1114 DOI: 10.1136/bjophthalmol-2020-317664
The impact of spectacle lenses for myopia control on visual functions / Y. Gao, E. W. Lim, A. Yang, B. Drobe, M. A. Bullimore // Ophthalmic Physiol. Opt. – 2021.- Vol.41 № 6 .- P. 1320 –1331 DOI: 10.1111/opo.12878
Influence of lenslet configuration on short-term visual performance in myopia control spectacle lenses / X.Li, C. Ding, Y.Li, E.W. Lim, Yi Gao, B. Fermigier, A. Yang, H. Chen, J. Bao // Frontiers in Neuroscience. – 2021. – Vol. 15.- P. 1-10. DOI: 10.3389/fnins.2021.667329
Tarutta E.P., Proskurina O.V., Tarasova N.A., Milash S.V., Markosyan G.A. [Long-term results of perifocal defocus spectacles in children with progressive myopia]. Vestnik oftalmologii [Bulletin of Ophthalmology]. 2019;135(5):46-53. (In Russ.). DOI: 10.17116/oftalma201913505146
Tarutta E.P., Ibatulin R.A., Milash S.V., Tarasova N.A., Proskurina O.V., Smirnova T.S., Markosyan G.A., Epishina M.V., Kovychev A.S. [The effect of Perifocal spectacles on peripheral defocus and myopia progression in children]. Rossiyskaya pediatricheskaya oftalmologiya [Russian Pediatric Ophthalmology]. 2014;9(4):53. (In Russ.)
Tarutta E.P., Proskurina O.V., Milash S.V., Ibatulin R.A., Tarasova N.A., Kovychev A.S., Smirnova T.S., Markosyan G.A., Khodjabekyan N.V., Maksimova M.V., Penkina A.V. [Spectacle-induced "Perifocal - M" peripheral defocus and myopia progression in children]. Rossiyskaya pediatricheskaya oftalmologiya [Russian Pediatric Ophthalmology]. 2015;2:33-37. (In Russ.)
Ibatulin R.A., Proskurina O.V., Tarutta E.P. [Multifactorial mechanisms of the therapeutic effect of perifocal spectacles (Perifocal-M) on myopia progression in children]. Oftalmologiya [Ophthalmology]. 2018;15(4):433-438. DOI: 10.18008/1816-5095-2018-4-433-438
Tarutta E.P., Proskurina O.V., Tarasova N.A., Arutyunyan S.G., Milash S.V., Markosyan G.A. [Short-term results of spectacle lenses with embedded highly aspheric lenslet rings Stellest™ for myopia control]. Rossiyskiy oftalmologicheskiy zhurnal [Russian Ophthalmological Journal]. 2022;15(4). (In Russ.). DOI: 10.21516/2072-0076-2022-15-4
Proskurina O.V., Tarutta E.P., Tarasova N.A., Milash S.V., Arutyunyan S.G., Markosyan G.A. [Two-year results of spectacle lenses with embedded highly aspheric lenslet rings Stellest™ for myopia control in children]. Rossiyskiy oftalmologicheskiy zhurnal [Russian Ophthalmological Journal]. 2024;17(2):25-31. (In Russ.). DOI: 10.21516/2072-0076-2024-17-2-25-31
Li X., Huang Y., Yin Z., Liu C., Zhang S., Yang A., Drobe B., Chen H., Bao J. Myopia control efficacy of spectacle lenses with aspherical lenslets: results of a 3-year follow-up study. Am. J. Ophthalmol. 2023;253:160-168. DOI: 10.1016/j.ajo.2023.03.030.
Peripheral refraction and ocular shape in children / D.O. Mutti, R.I. Sholtz, N. Friedman, K. Zadnik // Invest. Ophthalmol. Vis. Sci. – 2000.- Vol. 41.-P. 1022-1030.
Peripheral refractive errors in myopic, emmetropic, and hyperopic young subjects / A. Seidemann, F. Schaeffel, A. Guirao, N. Lopez-Gil, P. Artal // J. Opt. Soc. Am. A. – 2002.- Vol. 19,№12. -P. 2363-2373.
Relative peripheral refractive error and the risk of onset and progression of myopia in children. / D.O. Mutti, L. T. Sinnott, G. L. Mitchell, L. A. Jones-Jordan, M. L. Moeschberger, S. A. Cotter, R. N. Kleinstein, R. E. Manny, J. D. Twelker, K. Zadnik // Invest. Ophthalmol. Vis. Sci. – 2011.- Vol. 52, № 1.- P. 199-205. DOI: 10.1167/iovs.09-4826
Myopia: why study the mechanisms of myopia? Novel approaches to risk factors signaling eye growth / E. Tarutta, W. Chua, T. Young, E. Goldschmidt // Optom. Vis. Sci. – 2011.- Vol. 88, № 3.- P. 404-447.
Tarutta E.P., Tarasova N.A., Milash S.V., Proskurina O.V., Markosyan G.A. [The influence of various myopia correction devices on peripheral refraction depending on the direction of gaze]. Vestnik oftalmologii [Bulletin of Ophthalmology]. 2019;135(4):60-69. (In Russ.). DOI: 10.17116/oftalma201913504160
Proskurina O.V., Tarasova N.A., Markosyan G.A., Arutyunyan S.G., Milash S.V., Tarutta E.P. [Adaptation and visual quality in Stellest myopia control spectacle lenses with embedded highly aspheric lenslets]. Rossiyskaya pediatricheskaya oftalmologiya [Russian Pediatric Ophthalmology]. 2022;17(2):5-12. (In Russ.). DOI: 10.17816/rpoj97296
Logan N.S., Wolffsohn J.S. Role of un‑correction, under‑correction and over‑cor‑rection of myopia as a strategy for slowing myopic progression // Clin.Exp.Optom. – 2020.- Vol. 103, №2.- P. 133–137. DOI: 10.1111/cxo.12978. 121.
Under-correction or full correction of myopia? A meta-analysis / N. Yazdani, R. Sadeghi, A. Ehsaei, A. Taghipour, S.Hasanzadeh, L. Zarifmahmoudi, J.H. Shandiz // J. Optom.- 2021.- Vol.14, № 1.- P. 11-19 DOI: 10.1016/j.optom.2020.04.003
Wolffsohn J.S., Whayeb Y., Logan N.S., Weng R., International Myopia Institute Ambassador Group*. IMI-Global Trends in Myopia Management Attitudes and Strategies in Clinical Practice-2022 Update. Invest. Ophthalmol. Vis. Sci. 2023;64(6):1-14. DOI: 10.1167/iovs.64.6.6
Filinova O.B. [Dynamics of refraction and muscle balance in children during constant mild myopic defocusing in binocular and monocular alternating formats]. Rossiyskaya pediatricheskaya oftalmologiya [Russian Pediatric Ophthalmology]. 2009;1:31–33. (In Russ.)
Tarutta E.P., Khodjabekyan N.V., Filinova O.B., Kruzhkova G.V. [The effect of constant controlled mild myopic defocus on postnatal refractogenesis]. Vestnik oftalmologii [Bulletin of Ophthalmology]. 2008;124(6):21–24. (In Russ.)
Peripheraldefocusandmyopiaprogressioninmyopicchildrenrandomlyassignedtowearsinglevisionandprogressiveadditionlenses. / D.A. Berntsen, C.D. Barr, Mutti, K. Zadnik // Invest. Ophthalmol. Vis. Sci. – 2013.- Vol.54, №8.- P. 5761-5770. DOI:10.1167/iovs.13-11904.
Peripheral defocus with single-vision spectacle lenses in mypic children / Z. Lin, A. Martinez, X. Chen, L. Li // Optom. Vis. Sci. – 2010.- Vol. 87, №1.- P. 4–9. DOI:10.1097/OPX.0b013e3181c078f1.
Effects of myopic spectacle correction and radial refractive gradient spectacles on peripheral refraction / J. Tabernero, D. Vazquez, A. Seidemann, D. Uttenweiler, F. Schaeffel // Vision Res.- 2009.- Vol.49,№17.- P.2176–2186. DOI:10.1016/j.visres.2009.06.008.
Fedtke C., Ehrmann K., Bakaraju R.C. Peripheral refraction and spherical aberration profiles with single vision, bifocal and multifocal soft contact lenses // J. Optom. -2020.- Vol.13,№1.-P.15–28. DOI:10.1016/j.optom.2018.11.002.
Tarutta E.P., Arutyunyan S.G., Milash S.V. [Correction of ocular wavefront aberrations using contact lenses and their effect on the accommodative response]. Rossiyskiy oftalmologicheskiy zhurnal [Russian Ophthalmological Journal]. 2016;9(2):102-107. (In Russ.). DOI: 10.21516/2072-0076-2016-9-2-102-107
Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis / J. Huang, D. Wen, Q. Wang, C. McAlinden, I. Flitcroft, H. Chen, S.M. Saw, H. Chen, F. Bao, Y. Zhao, L. Hu, X. Li, R. Gao, W. Lu, Y. Du, Z. Jinag, A. Yu, H. Lian, Q. Jiang, Y. Yu, J. Qu // Ophthalmology.-2016.- Vol. 123, № 4.- P. 697-708. DOI: 10.1016/j.ophtha.2015.11.010
Gwiazda J., Hyman L., Hussein M., Everett D., Norton T.T., Kurtz D., Leske M.C., Manny R., Marsh-Tootle W., Scheiman M. A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children (comet 1). Invest. Ophthalmol. Vis. Sci. 2003;44(4):1492-1500.
Correction of Myopia Evaluation Trial 2 Study Group for the Pediatric Eye Disease Investigator Group. Progressive-addition lenses versus single-vision lenses for slowing progression of myopia in children with high accommodative lag and near esophoria. Invest. Ophthalmol. Vis. Sci. 2011;52(5):2749–2757.
Cheng D., Woo G.C., Drobe B., Schmid K.L. Effect of bifocal and prismatic bifocal spectacles on myopia progression in children: three-year results of a randomized clinical trial. JAMA Ophthalmol. 2014;132(3):258–264. DOI: 10.1001/jamaophthalmol.2013.7623.
Accommodation and related risk factors associated with myopia progression and their interaction with treatment in COMET children /J. Gwiazda, L. Hyman, T. Norton, M. Hussein, W. L. Marsh-Tootle, R. Manny, Y. Wang, D. Everett // Invest. Ophthal. Vis. Sci.- 2004.- T.45,№7.-P.2143-2151. DOI:10.1167/iovs.03-1306
Proskurina O.V., Tarasova N.A. [The effect of progressive and perifocal spectacles on refraction, accommodation, and muscle balance in children with progressive myopia]. Sovremennaya optometriya [Modern Optometry]. 2019;122(2):41-44. (In Russ.)
Proskurina O.V. [Methods of correction and treatment of accommodation disorders. Optical correction]. In: Katargina L.A., ed. Akkomodatsiya. Rukovodstvo dlya vrachey [Accommodation. A Guide for Physicians]. Moscow: Aprel; 2012. p. 84-93. (In Russ.)
Yang A., Lim S.Y., Wong Y.L., Yeo A., Rajeev N., Drobe B. Quality of life in presbyopes with low and high myopia using single-vision and progressive-lens correction. J. Clin. Med- 2021;10(8):1589. DOI: 10.3390/jcm10081589
Studies using concentric ring bifocal and peripheral add multifocal contact lenses to slow myopia progression in school‐aged children: a meta-analysis / S.-M. Li, M.‐T. Kang, S.-S. Wu, B. Meng, Y.-Y. Sun, S.-F. Wei, L. Liu, X. Peng, Z. Chen, F. Zhang, N. Wang // Ophthalmic Physiol. Opt.- 2017.- Vol. 37.- P. 51–59. DOI:10.1111/opo.12332
Aller T.A., Liu M., Wildsoet C.F. Myopia control with bifocal contact lenses: a randomized clinical trial // Optom. Vis. Sci. – 2016.-Vol. 93.- P. 344–352. DOI: 10.1097/OPX.0000000000000808
Gifford P., Gifford K.L. The future of myopia control contact lenses // Optometry and Vis.Sci. -2016 .- Vol.93, № 4.- P336-343. DOI: 10.1097/OPX.0000000000000762.
Queirós A. Astigmatic peripheral defocus with different contact lenses: review and meta-analysis / A. Queirós, D. Lopes-Ferreira, J.M. González-Méijome // Curr. Eye Res.- 2016 Vol. 41,№ 8.- P.1005-1015
MiSight Assessment Study Spain (MASS). A 2-year randomized clinical trial /A. Ruiz-Pomeda, B. Pérez-Sánchez, I. Valls, F. L. Prieto-Garrido // Graefes Arch. Clin. Exp. Ophthalmol.- 2018.- Vol.256, № 5.-P. 1011-1021.
Long-term effect of dual-focus contact lenses on myopia progression in children: a 6-year multicenter clinical trial / P. Chamberlain, A. Bradley, B. Arumugam, D. Hammond, J. McNally, N.S. Logan, D. Jones, C Ngo, Sofia C Peixoto-de-Matos 5, Chris Hunt 6, Graeme Young
Schulle K.L., Berntsen D.A., Sinnott L.T., Bickle K.M., Gostovic A.T., Pierce G.E., Jones-Jordan L.A., Mutti D.O., Walline J.J. Visual Acuity and over-refraction in myopic children fitted with soft multifocal contact lenses. Optom. Vis. Sci. 2018;95(4):292-298. DOI: 10.1097/OPX.0000000000001207
Kang P. Optical and pharmacological strategies of myopia control // Clin.Exp.Optom. – 2018. - Vol. 101, № 3.- P. 321-332. DOI: 10.1111/cxo.12666. Epub 2018 Feb 28.
Gong C.R., Troilo D., Richdale K. Accommodation and phoria in children wearing multifocal contact lenses // Optom. Vis. Sci. – 2017.- Vol. 94, №3.- P.353-360. DOI: 10.1097/OPX.0000000000001044.
A 3-year randomized clinical trial of MiSight lenses for myopia control / P. Chamberlain, S. Peixoto-de-Matos, N. Logan, C. Ngo, D. Jones, G. Young //Optometry and Vision Science.- 2019.- Vol. 96,№ 8.- P. 556-567. DO: 10.1097/OPX.0000000000001410
Avetisov S.E., Myagkov A.V., Egorova A.V., Poskrebysheva Zh.N., Zhabina O.A. [Results of a two-year clinical trial of myopia control using bifocal defocus soft contact lenses]. Vestnik oftalmologii [Bulletin of Ophthalmology]. 2021;137(3):5-12. (In Russ.). DOI: 10.17116/oftalma20211370315
Zarayskaya M.M., Bodrova S.G., Pashtaev N.P. [The effect of various myopia correction methods on the dynamics of its progression in children]. Vestnik Tambovskogo universiteta [Tambov University Reports]. 2014;19(4):1124-1127. (In Russ.)
Sitka M.M., Bodrova S.G., Pozdeeva N.A. [The efficacy of various optical correction methods for progressive myopia in children and adolescents based on a comparative evaluation of accommodation and eye length]. Oftalmologiya [Ophthalmology]. 2018;15(2S):65-72. (In Russ.). DOI: 10.18008/1816-5095-2018-2S-65-72
Roberts C.J., Adams G.G. Contact lenses in the management of high anisometropic amblyopia // Eye.- 2002.- Vol.16, №5.- P. 577–579
Vincent S.J. The use of contact lenses in low vision rehabilitation: optical and therapeutic applications. Clinical and Experimental Optometry. 2017;100(5):513-521. DOI: 10.1111/cxo.12562. Epub 2017 Jun 29.
Tarutta E.P., Verzhanskaya T.Yu. [Stabilizing effect of orthokeratological myopia correction (results of a ten-year follow-up study)]. Vestnik oftalmologii [Bulletin of Ophthalmology]. 2017;1:49-54. (In Russ.)
Tarutta E.P., Verzhanskaya T.Yu. [Possible mechanisms of the inhibitory effect of orthokeratology lenses on myopia progression]. Rossiyskiy oftalmologicheskiy zhurnal [Russian Ophthalmological Journal]. 2008;2(1):26-30. (In Russ.)
Tarutta E.P., Egorova T.S., Alyaeva O.O., Verzhanskaya T.Yu. [Ophthalmoergonomic and functional parameters in evaluating the efficacy of orthokeratological myopia correction in children and adolescents]. Rossiyskiy oftalmologicheskiy zhurnal [Russian Ophthalmological Journal]. 2012;5(3):63-66. (In Russ.)
Verzhanskaya T.Yu., Tarutta E.P., Manukyan I.V., Toloraya R.R. [The effect of orthokeratological contact lenses on anterior segment structures of the eye]. Rossiyskiy oftalmologicheskiy zhurnal [Russian Ophthalmological Journal]. 2009;2:30-34. (In Russ.)
Efficacyandacceptabilityoforthokeratologyforslowingmyopicprogressioninchildren: asystematicreviewandmeta-analysis / D. Wen, J. Huang, H. Chen, F. Bao, G. Savini, A. Calossi, H. Chen, X. Li, Q. Wang // J. Ophthalmol.-2015.-Vol. 2015.- P.:360806. DOI: 10.1155/2015/360806.
Orthokeratology for myopia control: a meta-analysis / J.K. Si, K. Tang, H.S. Bi, D.D. Guo, J.G. Guo, X.R. Wang// Optom. Vis. Sci.- 2015.- Vol.92, № 3.- P. 252-257. DOI: 10.1097/OPX.0000000000000505.
Orthokeratology to control myopia progression: a meta-analysis /Y. Sun, F. Xu, T. Zhang, M. Liu, D. Wang, Y. Chen, Q. Liu // PLOS ONE .- 2015.- Vol. 10,№ 4:e0124535. DOI: 10.1371/journal.pone.0124535. eCollection 2015.
Efficacy, safety and acceptability of orthokeratology on slowing axial elongation in myopic children by meta-analysis / S.M. Li, M.T. Kang, S.S. Wu, L.R. Liu, H. Li, Z. Chen, N. Wang // Curr. Eye. Res. – 2016.-Vol. 41, № 5.-P. 600-608. DOI:10.3109/02713683.2015.1050743.
Myopia control during orthokeratology lens wear in children using a novel study design / H.A. Swarbrick, A. Alharbi, K. Watt, E. Lum, P. Kang // Ophthalmology. – 2015.- Vol.122, № 3. –P. 620-630. DOI: 10.1016/j.ophtha.2014.09.028.
Na M., Yoo A. The effect of orthokeratology on axial length elongation in children with myopia: Contralateral comparison study// Jpn. J. Ophthalmol. -2018.-Vol.62, №3.- P. 327-334. DOI: 10.1007/s10384-018-0573-x
Cheah P.S., Norhani M., Bariah M.A., Myint M., Lye M.S., Azian A.L. Histomorphometric profile of the corneal response to short-term reverse-geometry orthokeratology lens wear in primate corneas: a pilot study. Cornea. 2008;27(4):461-470. DOI: 10.1097/ICO.0b013e318165642c.
Long-term changes in corneal morphology induced by overnight orthokeratology / A. Nieto-Bona, A. González-Mesa, M.P. Nieto-Bona, C. Villa-Collar, A. Lorente-Velázquez// Curr. EyeRes.- 2011.-Vol. 36, № 10.- P. 895-904. DOI:10.3109/02713683.2011.593723.
Tarutta E.P., Egorova T.S., Tarasova N.A., Chuvilina M.V. [Changes in accommodation and visual performance during functional treatment of progressive myopia]. Sovremennaya optometriya [Modern Optometry]. 2012;58(8):33-37. (In Russ.)
Tarutta E.P., Tarasova N.A. [State of habitual and resting accommodation tone in children and adolescents during hardware treatment of myopia]. Rossiyskiy oftalmologicheskiy zhurnal [Russian Ophthalmological Journal]. 2012;5(2):59-62. (In Russ.)
Tarutta E.P., Kiseleva T.N., Tarasova N.A., Epishina M.V. [Changes in accommodation parameters and ocular hemodynamic parameters during hardware treatment of myopia] // Russian Pediatric Ophthalmology. - 2014. - No. 1. - P. 42-45.
Tarutta E.P., Iomdina E.N., Tarasova N.A. [Non-surgical treatment of progressive myopia] // RMJ. Clinical Ophthalmology. - 2016. - No. 4. - P. 204-210.
Tarutta E.P. [Methods of correction and treatment of accommodation disorders. Functional treatment]. In: Katargina L.A., ed. [Accommodation. A Guide for Physicians]. - Moscow: Aprel, 2012. - P. 110-120.
Okovitov V.V. [Physiotherapy Methods in Ophthalmology] / Moscow: CVNIAG, 1999. - 158 p.].
Avetisov S.E., Makarov I.A., Kamenskikh T.G. [Physiotherapeutic methods]. In: [Ophthalmology. National Guidelines]. Moscow: Goetar-Media, 2009. - P. 187-199].
Lyalin A.N., Korepanov A.V., Chernykh N.A., Chermak S.B. [Results of prevention and treatment of acquired myopia using "Zenitsa" trainers in schoolchildren] // Bulletin of Orenburg State University. - 2015. - Vol. 187, No. 2. - P. 126-129.
Proskurina O.V., Tarasova N.A., Tarutta E.P. [The use of aspheric training glasses with dynamic refraction change in the horizontal meridian in the complex treatment of accommodation disorders in children] // Modern Optometry. - 2018. - Vol. 118, No. 8. - P. 25-29.
Aprelev A.E., Setko N.P., Iserkepova A.M. [Capabilities of conservative treatment methods in the restoration of visual functions in acquired myopia] // Practical Medicine. - 2019. - Vol. 17, No. 1. - P. 49-51.
DengL., Pang Y. Effect of outdoor activities in myopia control: meta-analysis of clinical studies // Optom. Vis. Sci. – 2019.- Vol. 96, № 4.- P. 276-282. DOI: 10.1097/OPX.0000000000001357.
Tarutta E.P., Tarasova N.A., Milash S.V., Markosyan G.A., Ramazanova K.A. [The effect of badminton playing on refraction, accommodation, and ocular hemodynamics in myopia] // Modern Optometry. - 2019. - No. 1. - P. 22-29.
Avetisov E.S., Livado E.I., Kurpan Yu.I. [Physical Education Classes in Myopia]. - Moscow: Fizkultura i Sport, 1983. - 103 p.
Brzheskiy V.V., Zayani Nabil. [Our experience with the use of Irifrin 2.5% in the therapy of habitual excessive accommodation tension in children] // Russian Ophthalmological Journal. - 2012; Vol. 5, No. 4. - P. 89-93.
Vorontsova T.N., Brzheskiy V.V., Efimova E.L., Prusinskaya S.M., Alekhina M.S., Ershova R.V., Zayani Nabil. [The efficacy of therapy for habitual excessive accommodation tension in children] // Russian Pediatric Ophthalmology. - 2010. - No. 2. - P. 17-19.
Tarutta E.P., Iomdina E.N., Tarasova N.A., Filinova O.B. [The effect of 2.5% Irifrin on accommodation parameters and refraction dynamics in patients with progressive myopia] // Russian Ophthalmological Journal. - 2010. - No. 2. - P. 30-33.
Vorontsova T.N. [Results of drug therapy for habitual excessive accommodation tension in children and students] // Russian Ophthalmological Journal. - 2016. - Vol. 9, No. 2. - P. 18-21. DOI:10.21516/2072-0076-2016-9-2-18-21
Zayani Nabil, Vorontsova T.N., Brzheskiy V.V. [Combined therapy of accommodation spasm in children] // Ophthalmological Vedomosti. - 2011. - Vol. 4, No. 1. - P. 23-27.
Tarutta E.P., Proskurina O.V., Tarasova N.A., Arutyunyan S.G., Markosyan G.A., Milash S.V. [Study design and short-term results of combined optical-pharmacological treatment of progressive myopia in children] // Russian Pediatric Ophthalmology. - 2023. - Vol. 18, No. 3. - P. 155-161. DOI: 10.17816/rpoj516533
Karazhaeva M.I., Saksonova E.O., Klebanov G.I., Lyubitskiy O.B., Guryeva N.V. [The use of flavonoid antioxidants in the complex treatment of patients with peripheral vitreochorioretinal dystrophies and dystrophic retinal detachment] // Bulletin of Ophthalmology. - 2004. - No. 4. - P. 14-17.
Matveeva A.V., Guseva M.R., Markova E.Yu., Ulshina L.V., Kuznetsova Yu.D. [Correction of oxidative stress and hemodynamic disorders in myopia] // Russian Pediatric Ophthalmology. - 2012. - No. 1. - P. 22-25.
Prikhodko V.A., Okovity S.V. [Opportunities and prospects of antioxidant therapy in the treatment of eye diseases] // Medical Council. - 2022. - No. 23. - P. 263-273. DOI:10.21518/2079-701X-2022-16-23-263-273].
Wilkinson C.P. Intervention for asymptomatic retinal breaks and latticed egeneration for retinal detachment // Cochrane. Database.Syst. Rev. – 2014.- Vol.3, №9.-P.:CD003170. DOI: 10.1002/14651858.CD003170.pub4.
Neroev V.V., Ilyukhin P.A. [Retinal detachment]. In: Avetisov S.E., Egorov E.A., Moshetova L.K., Neroev V.V., Takhchidi Kh.P., eds. [Ophthalmology. National Guidelines]. Moscow: Goetar-Media, 2009. - P. 639-647.
Shaimova V.A., Boyko E.V., Pozdeeva O.G. [Laser retinal photocoagulation in peripheral dystrophies]. In: Shaimova V.A., ed. [Atlas. Peripheral Retinal Dystrophies. Optical Coherence Tomography. Laser Retinal Photocoagulation]. - St. Petersburg: Chelovek, 2015. - P. 213-235.
Boyko E.V., Suetov A.A., Maltsev D.S. [Lattice retinal dystrophy] // Bulletin of Ophthalmology. - 2014. - Vol. 30, No. 2. - P. 77-82.
Vorontsova T.N. [Possibilities of using a diode laser in retinal diseases in children] // Oftal'mologicheskie vedomosti. - 2008. - Vol. 1, № 1. - P. 24 - 28. (In Russ.)
Vorontsova T.N., Somov E.E. [Abiotrophies and retinal dystrophies in children]. In: Somov E.E., ed. Oftal'mopatologiya detskogo vozrasta. - St. Petersburg: Chelovek, 2019. - P. 193-211. (In Russ.)
[Peripheral vitreochorioretinal dystrophies in patients with myopia] / V.V. Il'nitskiy, E.O. Saksonova, N.V. Gur'eva, N. Georgiev, L.M. Balashova // Vestnik oftal'mologii. - 1993. - Vol. 109, № 4. - P. 18-20. (In Russ.)
Egorov E.A., Egorova T.E. [Ophthalmopharmacology]. In: Oftal'mologiya. Natsional'noe rukovodstvo. Moscow: Goetar-Media, 2009. - P. 200-263. (In Russ.)
Local anaesthesia for ophthalmic surgery-new guidelines from the Royal College of Anaesthetists and the Royal College of Ophthalmologists / C.M. Kumar, T. Eke, C. Dodds, J.S. Deane, N. El-Hindy, R.L. Johnston, K.L. Kong, H.A. McLure, P. Shah, S.Q. Tighe, S.B. Vohra // Eye (Lond).- 2012.- Vol. 26,№6.- P.897-898. DOI: 10.1038/eye.2012.82.
Avetisov E.S., Rozenblyum Yu.Z., Tarutta E.P. [Prevention of myopia] // Vestnik oftal'mologii. - 1989. - № 6. - P. 3-6. (In Russ.)
Tarutta E.P., Iomdina E.N., Kruzhkova G.V., Markosyan G.A. [Long-term results of sclera-reconstructive treatment of progressive myopia] // Rossiyskiy oftal'mologicheskiy zhurnal. - 2011. - Vol. 4, № 1. - P. 71-75. (In Russ.)
Tarutta E.P. [A pathogenetically substantiated system for diagnosis, prognosis, prevention, and sclera-reconstructive treatment of pathological myopia] // Rossiyskaya pediatricheskaya oftal'mologiya. - 2008. - № 1. - P. 25-28. (In Russ.)
Episheva S.N., Venger G.E. [Efficacy of scleral reinforcement using texplan in progressive myopia] // Oftal'mologicheskiy zhurnal. - 1998. - № 1. - P. 8-11. (In Russ.)
WardB., TaruttaE.P, MayerM.J. The efficacy and safety of posterior pole buckles in the control of progressive high myopia // Eye.- 2009.- Vol. 23.- P. 2169-2174.
[New technologies of sclera-strengthening treatment for progressive myopia] / E.N. Iomdina, E.P. Tarutta, G.A. Markosyan, L.D. Andreeva, Zh.N. Ivashchenko, A.R. Korigodskiy, S.I. Shkurenko, G. Wollensak // Pediatricheskaya oftal'mologiya. - 2008. - № 1. - P. 28-30. (In Russ.)
Tarutta E.P. [Surgical prevention of myopia progression. Indications and methods] // Refraktsionnaya khirurgiya i oftal'mologiya. - 2002. - № 3. - P. 29-32. (In Russ.)
Tarutta E.P. [Sclera-strengthening treatment and prevention of complications of progressive myopia] // Zritel'nye funktsii i ikh korrektsiya u detey / In: S.E. Avetisov, T.P. Kashchenko, A.M. Shamshinova. - Moscow: Meditsina, 2005. - P. 191-202. (In Russ.)
[Scleral reinforcement in progressive myopia using a synthetic graft with biologically active properties] / E.P. Tarutta, E.N. Iomdina, Zh.N. Ivashchenko, G.A. Markosyan, L.D. Andreeva, S.I. Shkurenko // Glaz. - 2007. - № 1. - P. 14-22. (In Russ.)
[Clinical and experimental study of the efficacy of repeated sclera-strengthening injection in progressive myopia] / E.P. Tarutta, L.D. Andreeva, M.I. Vinetskaya, E.N. Iomdina // Oftal'mologicheskiy zhurnal. - 1991. - № 6. - P. 365-368. (In Russ.)
Tarutta E.P., Iomdina E.N., Akhmedzhanova E.V. [Progressive myopia in children: to treat or not to treat?] // Vestnik oftal'mologii. - 2005. - № 2. - P. 5-8. (In Russ.)
Tarutta E.P., Vakhidova L.T. [Tactics of sclera-strengthening treatment of myopia in children with an increased risk of its progression] // Vestnik oftal'mologii. - 1998. - № 6. - P. 29-31. (In Russ.)
[Efficacy of surgical treatment of progressive myopia in children and adolescents] / N.A. Puchkovskaya, A.S. Senyakina, G.G. Melikov, N.N. Bushueva // Oftal'mologicheskiy zhurnal. - 1984. - № 8. - P. 449-454. (In Russ.)
Modified posterior scleral reinforcement as a treatment for high myopia in children and its therapeutic effect / Z. Miao, L. Li, X. Meng, L. Guo, D.Cao,Y. Jia, D. He,L. Huang, L. Wang // BioMed. ResearchInternational. - 2019.- Vol. 2019.-ID 5185780. DOI:10.1155/2019/5185780.
Muldashev E.R., Gulimova V.U., Bulatova R.T. [Regenerative surgery of myopia]. In: Muldashev E.R., ed. Regenerativnaya meditsina. Vol. 1. Biomaterialy alloplant v oftal'mokhirurgii. - Ufa: State Republican Publishing House "Bashkortostan", 2014. - P. 138-160. (In Russ.)
Svirin A.V. [Application of sclera-strengthening collagenoplasty with a trophic component in the treatment of high progressive myopia] // Vestnik oftal'mologii. - 1994. - № 1. - P. 11 - 13. (In Russ.)
Identification of a putative polyketide synthase gene involved in usnic acid biosynthesis in the lichen Nephromopsis pallescens / Y. Wang, C. Geng, X. Yuan, M. Hua, F. Tian, C. Li // PLoS ONE.- 2018.-Vol. 13, №7.- e0199110.DOI: 10.1371/journal. pone.0199110
Kurek V.V., Kulagin A.E. [Pediatric Anesthesiology and Intensive Care: A Practical Guide] / V.V. Kurek, A.E. Kulagin. - Moscow: LLC "Medical Information Agency Publishing House", 2011. - 992 p. (In Russ.)
Turlekieva Zh.M., Sultankulova G.T., Ordakhanov U.E. [Anesthesia for ophthalmic surgeries in children] // Vestnik KazNMU. - 2016. - № 1. - P. 255-256. (In Russ.)
Anesthesia in Ophthalmology: A Guide / Ed. by H.P. Takhchidi, S.N. Sakhnov, V.V. Myasnikova, P.A. Galenko-Yaroshevsky. – M.: Medical Information Agency LLC, 2007. – 552 p.
Somov E.E. [Scleroplasty] / E.E. Somov. - St. Petersburg: Pediatric Medical Institute, 1995. - 144 p. (In Russ.)
Astakhov Yu.S., Vokhmyakov A.V. [Endophthalmitis: prevention, diagnosis, treatment] // Oftal'mologicheskie vedomosti. - 2008. - Vol. 1, № 1. - P. 35-45. (In Russ.)
Drack A.V., Nucci P. Refractive surgery in children // Ophthalmol. Clin. North. Am. -2001.- Vol.14,№3.- P 457-466. DOI: 10.1016/s0896-1549(05)70244-3.
Intraoperative patient experience and postoperative visual quality after SMILE and LASIK in a randomized, paired-eye, controlled study / I.B. Damgaard, M. Ang, M. Farook, H.M. Htoon, J.S. Mehta // J. Refract. Surg. - 2018. - Vol. 34, № 2. - P. 92-99. DOI: 10.3928/1081597X-20171218-01.
Zhang Y., Chen Y. J. A Randomized comparative study of topography-guided versus wavefront-optimized FS-LASIK for correcting myopia and myopic astigmatism // J. Refract. Surg. – 2019. – Vol. 35, № 9.- P. 575-582. DOI: 10.3928/1081597X-20190819-01.
Ganesh S., Brar S., Patel U. Comparison of ReLEx SMILE and PRK in terms of visual and refractive outcomes for the correction of low myopia // Int. Ophthalmol. - 2018 Vol. 38, № 3.- P. 1147-1154. DOI: 10.1007/s10792-017-0575-6.
Contrast sensitivity after wavefront-guided and wavefront-optimized prk and lasik for myopia and myopic astigmatism. D.S. Ryan, R.K. Sia, J. Rabin, B.A. Rivers, R.D. Stutzman, J.F. Pasternak, J.B. Eaddy, L.A. Logan, R.S. Bower // J. Refract. Surg. – 2018.- Vol.34, № 9.- P. 590-596. DOI: 10.3928/1081597X-20180716-01.
Risk evaluation of human corneal stromal lenticules from SMILE for reuse / Y. Shang, Y. Li, Z. Wang, X. Sun, F. Zhang // J. Refract. Surg. - 2021.- Vol.37, №1.- P. 32-40. DOI: 10.3928/1081597X-20201030-03.
The effectiveness of social media and in-person interventions for low back pain conditions in nursing personnel (SMILE) / S.S. Kazemi, S.S. Tavafian, C.E. Hiller, A. Hidarnia, A. Montazeri // Nurs. Open. – 2021.- Vol.8, №3.- P. 1220-1231. DOI: 10.1002/nop2.738. Epub 2020 Dec 15.
Artisan versus Artiflex phakic intraocular lens implantation in the treatment of moderate to high myopia: meta-analysis / C. Hou, H. Li, J. Li, J. Li, H. Peng, Q. Wang // BMC Ophthalmol. – 2021.- Vol.21, №1.- P. 171. DOI: 10.1186/s12886-021-01930-6.
Posterior chamber phakic intraocular lens implantation: comparative, multicentre study in 351 eyes with low-to-moderate or high myopia / K. Kamiya, K. Shimizu, A. Igarashi, Y. Kitazawa, T. Kojima, T. Nakamura, Y. Oka, R. Matsumoto // Br. J. Ophthalmol. – 2018.- Vol. 102, №2.- P. 177-181. DOI: 10.1136/bjophthalmol-2017-310164. Epub 2017 Jun 13.
Avetisov E.S. Rukovodstvo po detskoy oftalmologii / E. S. Avetisov, E. I. Kovalevskiy, A. V. Khvatova. – M.: Meditsina. - 1987. – 494 p.
Fundamentalnye issledovaniya biokhimicheskikh i ultrastrukturnykh mekhanizmov patogeneza progressiruyushchey miopii / E.N. Iomdina, E.P. Tarutta, N.Yu. Ignateva, I.A. Kostanyan, N.I. Minkevich, D.L. Kakuev, V.V. Radchenko, A.B. Shekhter, N.A. Danilov, N.G. Kvaratskheliya, S.G. Chernysheva // Rossiyskiy oftalmologicheskiy zhurnal. – 2008.- № 3.- P. 7-12
Dashevskiy A.I. K voprosu o razvitii psevdomiopii i miopii i ikh profilaktike // Oftalmologicheskiy zhurnal.- 1988.- №3.- P. 132-136
Appendix A1. Working Group Composition
Brzheskiy Vladimir Vsevolodovich, MD, Prof., Association of Ophthalmologists LLC;
Vorontsova Tatyana Nikolaevna, PhD, Association of Ophthalmologists LLC;
Dogadova Lyudmila Petrovna, PhD, Association of Ophthalmologists LLC;
Zhukova Olga Vladimirovna, MD, Association of Ophthalmologists LLC;
Iomdina Elena Naumovna, Dr. Biol. Sci., Prof., Association of Ophthalmologists LLC;
Markova Elena Yuryevna, MD, Association of Ophthalmologists LLC;
Markosyan Gayane Aykazovna, MD, Association of Ophthalmologists LLC;
Milash Sergey Viktorovich, Physician, Association of Ophthalmologists LLC;
Proskurina Olga Vladimirovna, Dr. of Med. Sci., Association of Ophthalmologists LLC;
Saydasheva Elvira Irekovna, MD, Prof., Association of Ophthalmologists LLC;
Tarutta Elena Petrovna, Group Head, MD, Professor, Association of Ophthalmologists LLC;
Khodzabekyan Narine Vladimirovna, MD, Association of Ophthalmologists LLC
No conflict of interest is declared.
Appendix A2. Methodology for Developing Clinical Guidelines
The National Protocol for the Diagnosis and Treatment of Myopia in Children was developed taking into account the "Rules for the Provision of Medical Care to Children with Diseases of the Eye, its Adnexa and Orbit", approved by Order of the Russian Ministry of Health No. 442n dated October 25, 2012 (registered with the Russian Ministry of Justice on December 20, 2012, No. 26208), which sets out the basic provisions for the organization of pediatric ophthalmological care. Unlike the "Rules", which outline the main stages of providing ophthalmological care to children, the "Clinical Guidelines" are methodological recommendations for physicians that detail all stages of ophthalmological care and differentiated approaches in various situations, adhering to the principles of evidence-based medicine.
Methods used for evidence collection/selection: electronic database search; analysis of current scientific developments on the problem of childhood myopia in Russia and abroad; synthesis of the practical experience of Russian and foreign colleagues.
When selecting publications as potential sources of evidence, the methodology used in each study is examined to ensure its reliability. The result of this examination affects the level of evidence assigned to the publication, which in turn affects the strength of the recommendations derived from it.
A preliminary version of these guidelines was reviewed by independent experts who were asked to comment primarily on whether the interpretation of the evidence underlying the recommendations is reliable and accessible to practicing physicians and patients.
Feedback has been received from ophthalmologists specializing in myopia and primary care physicians regarding the clarity of presentation and the importance of the recommendations as a practical tool for everyday medical practice.
Comments received from experts were carefully systematized and discussed by the chairs and members of the working group. Every item was discussed. Changes and additions recommended as a result of the discussion were incorporated into the text of the guidelines.
Target audience for these clinical guidelines:
Ophthalmologists;
General practitioners (family physicians);
District general practitioners;
District general practitioners
Pediatricians;
Urban (district) pediatricians;
District pediatricians;
Adolescent general practitioners
Child and adolescent hygiene physicians;
Physiotherapists;
Medical opticians-optometrists
Table 1. Levels of Evidence (LoE) grading scale for diagnostic methods (diagnostic interventions)
LoE | Definition |
|---|---|
1 | Systematic reviews of studies with reference standard control or systematic reviews of randomized controlled trials with meta-analysis |
2 | Individual studies with reference standard control or individual randomized controlled trials and systematic reviews of studies of any design, except randomized controlled trials, with meta-analysis |
3 | Studies without consecutive reference standard control or studies with a reference standard not independent of the test method, or non-randomized comparative studies, including cohort studies |
4 | Non-comparative studies, case report |
5 | There is only a rationale for the mechanism of action or expert opinion |
Table 2. Scale for grading levels of evidence (LE) for prevention, treatment, and rehabilitation methods (preventive, therapeutic, and rehabilitative interventions)
LoE | Definition |
|---|---|
1 | Systematic review of RCTs with meta-analysis |
2 | Individual RCTs and systematic reviews of studies of any design except RCTs, with meta-analysis |
3 | Non-randomized comparative studies, including cohort studies |
4 | Non-comparative studies, case reports or case series, case-control studies |
5 | There is only a rationale for the mechanism of action of the intervention (preclinical studies) or expert opinion |
Table 3. Scale for grading grades of recommendation (GR) for prevention, diagnostic, treatment, and rehabilitation methods (preventive, diagnostic, therapeutic, and rehabilitative interventions)
GoR | Definition |
|---|---|
A | Strong recommendation (all considered efficacy criteria (outcomes) are important, all studies are of high or acceptable methodological quality, and their conclusions on the outcomes of interest are consistent) |
B | Conditional recommendation (not all considered efficacy criteria (outcomes) are important, not all studies are of high or acceptable methodological quality, and/or their conclusions on the outcomes of interest are inconsistent) |
C | Weak recommendation (lack of adequate quality evidence (all considered efficacy criteria (outcomes) are unimportant, all studies are of low methodological quality, and their conclusions on the outcomes of interest are inconsistent) |
Procedure for updating clinical guidelines
The mechanism for updating clinical guidelines provides for their systematic revision at least once every three years, as well as upon the emergence of new evidence-based medicine data on the diagnosis, treatment, prevention, and rehabilitation of specific diseases, or in the presence of justified additions/comments to previously approved clinical guidelines, but no more frequently than once every 6 months.
Appendix A3. Reference Materials
These clinical guidelines were developed taking into account the following regulatory legal documents:
Order of the Ministry of Health of the Russian Federation No. 442n dated October 25, 2012 "On Approval of the Rules for the Provision of Medical Care to Children with Diseases of the Eye, its Adnexa and Orbit" (as amended on July 27, 2020)
Order of the Ministry of Health of the Russian Federation No. 902n dated November 12, 2012 "On Approval of the Rules for the Provision of Medical Care to Adults with Diseases of the Eye, its Adnexa and Orbit" (as amended on February 1, 2022)
Order of the Ministry of Health of the Russian Federation No. 567n dated June 2, 2021 "On Approval of the Standard of Medical Care for Children with Myopia (Diagnosis, Treatment, and Follow-up Care)".
Order of the Ministry of Health of the Russian Federation No. 203n dated May 10, 2017 "On Approval of Criteria for Assessing the Quality of Medical Care"
Decree of the Government of the Russian Federation No. 2406-r dated October 12, 2019
State Register of Medicines (as of August 30, 2024)
Order of the Ministry of Health of the Russian Federation No. 514n dated August 10, 2017 "On the Procedure for Conducting Preventive Medical Examinations of Minors" (as amended on November 19, 2020).
Order of the Russian Ministry of Health No. 29n dated January 28, 2021 "On Approval of the Procedure for Conducting Mandatory Preliminary and Periodic Medical Examinations of Employees Provided for in Part Four of Article 213 of the Labor Code of the Russian Federation, the List of Medical Contraindications to Performing Work with Harmful and (or) Hazardous Production Factors, as well as Work Requiring Mandatory Preliminary and Periodic Medical Examinations"
Order of the Ministry of Health of the Russian Federation No. 909n dated November 12, 2012 "On Approval of the Rules for the Provision of Medical Care to Children in the Field of 'Anesthesiology and Reanimatology'" (as amended on July 9, 2013).
Order of the Ministry of Health of the Russian Federation No. 919n dated November 15, 2012 "On Approval of the Rules for the Provision of Medical Care to Adults in the Field of 'Anesthesiology and Reanimatology'" (as amended on September 14, 2018)
GOST 30808-2002 Spectacle Lenses. General Specifications.
Federal Law of the Russian Federation No. 323-FZ dated November 21, 2011 "On the Fundamentals of Protecting the Health of Citizens in the Russian Federation".
Table 1. Drugs used for the diagnosis of myopia
Drugs | Route of administration | Doses |
|---|---|---|
Tropicamide** 1%, eye drops | Into the conjunctival sac | 1-2 drops, 2 times with an interval of 5 minutes |
Cyclopentolate 1%, eye drops | Into the conjunctival sac | 1-2 drops, 2 times with an interval of 15-20 minutes |
#Atropine** 1%, eye drops | Into the conjunctival sac | 1-2 drops 2 times a day for 3 days; on the fourth day, instill 1 time 1-2 hours before the examination by an ophthalmologist |
Table 2. Drugs used in the complex treatment of progressive and complicated myopia
ATC code | INN | Method of administration and doses | Indications for use in accordance with the instructions |
|---|---|---|---|
Phenylephrine (S01FB01) | Phenylephrine 2.5% - eye drops | For children aged 6 years and older and adults, 1 drop once daily at bedtime, for 4 weeks, in courses 4 times a year | Prevention of asthenopia and accommodation disorders in patients with high visual load. Treatment of pseudomyopia (accommodation disorders) and prevention of true myopia progression in patients with high visual load |
Tropicamide in combination with other drugs (S01FA56) | Tropicamide + phenylephrine - eye drops | For children aged 12 years and older and adults, 1 drop once daily at bedtime, for 2-4 weeks | For accommodation disorders and therapy of progressive myopia (as part of combination therapy) |
Other drugs for the treatment of eye diseases (S01XA) | Methylethylpyridinol 1% - eye drops | For adults, 1-2 drops 2-3 times a day, for 30 days, in courses 2-3 times a year [209] | Treatment of myopia complications |
Multivitamins in combination with other agents (A11AB) | #Multivitamins + other drugs | According to the instructions | In the complex therapy of myopia |
Appendix B. Physician Action Algorithms
Myopia

Appendix C. Patient Information
Myopia is the most common optical defect. In a myopic eye, light rays are refracted more than necessary, with the result that the image is formed not on the retina (the light-sensitive structure of the eye), but in front of it, making it unclear and blurred. Over the past 20 years, the prevalence of myopia has increased catastrophically worldwide. Among young people in the US and Europe, it reaches 40-45%. In our country, it is observed in 30% of school graduates, and in gymnasiums and lyceums this figure approaches 50%. It is hard not to notice that in the most computerized and fast-learning region of the world—Southeast Asia (Taiwan, Hong Kong, Singapore)—the prevalence of myopia exceeds 70%. And such a "surge" in incidence cannot be blamed solely on heredity, as this contradicts the laws of genetics. Clearly, various environmental factors make a harmful contribution. These include early increased visual load, various electronic media devices, gaming devices, and a sedentary lifestyle among children—where are you, our noisy and long outdoor games? A certain role in this is played by general health, which corresponds to the norm in at best 10% of children, as well as poor ecology. As you can see, there are many factors, both external and internal, but in order to lead to the development of myopia, they must be mediated through some substrate within the eye itself. And this substrate is weakened accommodation—an adaptive mechanism that allows a healthy person to see clearly at any distance, both far and near. It was precisely accommodation disorders that were identified as the "weak link" in the origin of myopia by Professor E.S. Avetisov almost 60 years ago.
To prevent the development of myopia, specialists at the Helmholtz National Medical Research Center of Eye Diseases developed the method of "constant mild myopic defocus" using specially selected glasses. Children at high risk of developing myopia (especially children of myopic parents), with signs of "pre-myopia," or with early myopia are prescribed glasses for continuous wear (in the first case, corrective glasses with positive lenses; in the second case, alternating daily between corrective glasses with positive lenses for one eye and corrective glasses with weak negative lenses for the other) so as to create a mild myopic defocus in the eye. The power of the lenses is calculated and selected individually to ensure adequate distance visual acuity for life and study. Another optical method for correction and control of mild and moderate myopia progression is glasses that form peripheral myopic defocus for continuous wear.
An effective method for controlling the progression of myopia—nocturnal orthokeratology correction—was developed in the USA, but quickly spread worldwide and has been used for over 15 years at the Helmholtz National Medical Research Center and other clinics in Russia. Literally translated, "orthokeratology" means "correction of the cornea." In reality, these lenses help to "tailor" the shape and refractive power of the cornea to the existing degree of myopia so that the "hyperopic" cornea corrects the myopia caused by excessive eye length. This is achieved through a special, complex lens shape that exerts a planned, dosed effect on the anterior surface of the cornea overnight, predominantly on its epithelial layer. The result of this effect persists throughout the day and is maintained again by the lens at night, allowing patients to go without any correction during the day and have a visual acuity close to or equal to 100%. The result itself is excellent, allowing for sports and other active pursuits. In addition, orthokeratology slows down the progression of myopia. Of course, children must be monitored: an ultrasound examination is necessary to assess myopia progression via changes in eye length, as well as corneal microscopy to detect potential complications before their clinical manifestation. If myopia progression is detected, orthokeratology can be combined with other types of stabilizing treatment: hardware-based, pharmacological, and/or surgical. If, after reaching 18–20 years of age with stable myopia, the patient wishes to stop wearing orthokeratology lenses and undergo corrective surgery, nothing will prevent them from doing so. They simply need to stop using the lenses, wait under a doctor's supervision for their myopia to return, and then correct it using one of the existing laser surgical methods.
In addition to optical methods, hardware-based treatment methods are widely used for treating progressive myopia. A comprehensive program of hardware treatment for myopia is effective, including laser stimulation of the ciliary zone, optic-reflex training, magnetophoresis, acupuncture, and collar-zone massage. After treatment, the tonus and functional capacity of the ciliary muscle normalize, ocular hemodynamics improves, and the rate of myopia progression slows down.
However, not all children achieve halted myopia progression. In some cases, despite optical methods and hardware treatment, myopia continues to progress. In these cases, scleroplasty is used. Techniques for major and minor scleroplasty have been developed. Minor scleroplasty reinforces the most compliant supero-external area of the sclera. A synthetic material is used for minor scleroplasty. Major scleroplasty is performed for high myopia with a rapid rate of progression and involves reinforcing the posterior pole of the sclera.
If a child is diagnosed with myopia or is at risk for developing myopia, ophthalmological monitoring is required at least once every 6 months.
Adults with progressive myopia require ophthalmological monitoring at least once every 6 months, and those with stable myopia, once a year.
Appendix G. Assessment Scales, Questionnaires, and Other Evaluation Tools
Not used.